,Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
189,GO_Biological_Process_2017b,determination of left/right asymmetry in nervous system (GO:0035545),4/270,8.562439270156203e-05,0.0042211174663762,0,0,21.177228786251344,198.3361907823317,HDAC4;GDA;ADORA1;NRG1
183,GO_Biological_Process_2017b,stomatogastric nervous system development (GO:0007421),4/244,5.7811886527093854e-05,0.0042211174663762,0,0,23.502380952380957,229.34366370910396,HDAC4;GDA;ADORA1;NRG1
184,GO_Biological_Process_2017b,ganglion development (GO:0061548),4/244,5.7811886527093854e-05,0.0042211174663762,0,0,23.502380952380957,229.34366370910396,HDAC4;GDA;ADORA1;NRG1
185,GO_Biological_Process_2017b,nervous system development (GO:0007399),4/244,5.7811886527093854e-05,0.0042211174663762,0,0,23.502380952380957,229.34366370910396,HDAC4;GDA;ADORA1;NRG1
186,GO_Biological_Process_2017b,autonomic nervous system development (GO:0048483),4/245,5.8738369257619625e-05,0.0042211174663762,0,0,23.40367516301126,228.00837200619767,HDAC4;GDA;ADORA1;NRG1
187,GO_Biological_Process_2017b,peripheral nervous system development (GO:0007422),4/255,6.861136518290663e-05,0.0042211174663762,0,0,22.45987478656801,215.3239956617481,HDAC4;GDA;ADORA1;NRG1
188,GO_Biological_Process_2017b,neural tube development (GO:0021915),4/259,7.288132173784914e-05,0.0042211174663762,0,0,22.103081232493,210.56894145333203,HDAC4;GDA;ADORA1;NRG1
190,GO_Biological_Process_2017b,neurogenesis (GO:0022008),4/272,8.810505120437242e-05,0.0042211174663762,0,0,21.017057569296377,196.23586072232465,HDAC4;GDA;ADORA1;NRG1
191,GO_Biological_Process_2017b,regulation of protein homodimerization activity (GO:0043496),2/16,9.11177629974979e-05,0.0042211174663762,0,0,178.28571428571428,1658.6557887027404,HDAC4;NRG1
192,GO_Biological_Process_2017b,regulation of protein heterodimerization activity (GO:0043497),2/17,0.00010321185160705684,0.0042211174663762,0,0,166.39166666666668,1527.2636618368022,HDAC4;NRG1
193,GO_Biological_Process_2017b,synapse assembly (GO:0007416),4/285,0.00010552793665940568,0.0042211174663762,0,0,20.031520081342144,183.41931147576096,HDAC4;GDA;ADORA1;NRG1
194,GO_Biological_Process_2017b,central nervous system development (GO:0007417),4/333,0.0001920228385167544,0.0070408374122809,0,0,17.06730351715154,146.06021263737347,HDAC4;GDA;ADORA1;NRG1
196,GO_Biological_Process_2017b,ERBB2-ERBB3 signaling pathway (GO:0038133),2/39,0.0005558029199639917,0.0174680917702968,0,0,67.38175675675676,505.03278857308806,ERBIN;NRG1
195,GO_Biological_Process_2017b,ERBB2-ERBB4 signaling pathway (GO:0038135),2/38,0.0005275811191520497,0.0174680917702968,0,0,69.25694444444444,522.6965599068795,ERBIN;NRG1
197,GO_Biological_Process_2017b,ERBB2 signaling pathway (GO:0038128),2/41,0.0006144037622474869,0.0180225103592596,0,0,63.9198717948718,472.6783914538256,ERBIN;NRG1
161,WikiPathways_2019_Human,Cardiac Hypertrophic Response WP2795,2/55,0.0011044055879804,0.0242969229355689,0,0,47.00235849056604,320.01311451477966,HDAC4;NRG1
162,WikiPathways_2019_Human,MicroRNAs in cardiomyocyte hypertrophy WP1544,2/84,0.0025528513200634,0.0280813645206975,0,0,30.335365853658537,181.11864810557336,HDAC4;NRG1
198,GO_Biological_Process_2017b,epidermal growth factor receptor signaling pathway (GO:0007173),2/55,0.0011044055879804,0.0303711536694612,0,0,47.00235849056604,320.01311451477966,ERBIN;NRG1
0,GO_Biological_Process_2018,ERBB2 signaling pathway (GO:0038128),2/39,0.0005558029199639917,0.0458323611442509,0,0,67.38175675675676,505.03278857308806,ERBIN;NRG1
1,GO_Biological_Process_2018,nervous system development (GO:0007399),4/455,0.0006278405636198764,0.0458323611442509,0,0,12.373139056065884,91.22992959648268,HDAC4;GDA;ADORA1;NRG1
19,GO_Biological_Process_2018,presynaptic membrane organization (GO:0097090),1/11,0.0098579216348164,0.0499609276067028,0,0,117.48235294117649,542.7073703814344,PTPRD
44,GO_Biological_Process_2018,establishment or maintenance of apical/basal cell polarity (GO:0035088),1/18,0.0160833123117468,0.0499609276067028,0,0,69.08304498269896,285.3111137768628,ERBIN
45,GO_Biological_Process_2018,heart trabecula morphogenesis (GO:0061384),1/18,0.0160833123117468,0.0499609276067028,0,0,69.08304498269896,285.3111137768628,NRG1
46,GO_Biological_Process_2018,anion transmembrane transport (GO:0098656),1/18,0.0160833123117468,0.0499609276067028,0,0,69.08304498269896,285.3111137768628,SLC13A3
16,GO_Biological_Process_2018,positive regulation of protein sumoylation (GO:0033235),1/9,0.0080724193100501,0.0499609276067028,0,0,146.86764705882354,707.7995527019895,HDAC4
15,GO_Biological_Process_2018,regulation of striated muscle cell differentiation (GO:0051153),1/8,0.0071785287204102,0.0499609276067028,0,0,167.85714285714286,828.6537822644398,NRG1
14,GO_Biological_Process_2018,histone H4 deacetylation (GO:0070933),1/8,0.0071785287204102,0.0499609276067028,0,0,167.85714285714286,828.6537822644398,HDAC4
13,GO_Biological_Process_2018,cardiac muscle hypertrophy (GO:0003300),1/8,0.0071785287204102,0.0499609276067028,0,0,167.85714285714286,828.6537822644398,HDAC4
12,GO_Biological_Process_2018,ventricular trabecula myocardium morphogenesis (GO:0003222),1/8,0.0071785287204102,0.0499609276067028,0,0,167.85714285714286,828.6537822644398,NRG1
11,GO_Biological_Process_2018,asymmetric protein localization (GO:0008105),1/8,0.0071785287204102,0.0499609276067028,0,0,167.85714285714286,828.6537822644398,ERBIN
10,GO_Biological_Process_2018,negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433),2/140,0.0069164024538674,0.0499609276067028,0,0,17.97463768115942,89.40332276954871,HDAC4;ERBIN
9,GO_Biological_Process_2018,peptidyl-lysine deacetylation (GO:0034983),1/7,0.0062838777740325,0.0499609276067028,0,0,195.843137254902,992.8792720611536,HDAC4
8,GO_Biological_Process_2018,regulation of protein heterodimerization activity (GO:0043497),1/7,0.0062838777740325,0.0499609276067028,0,0,195.843137254902,992.8792720611536,NRG1
7,GO_Biological_Process_2018,transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),1/6,0.0053884659389882,0.0499609276067028,0,0,235.0235294117647,1227.644124299904,PTPRD
6,GO_Biological_Process_2018,negative regulation of glycolytic process (GO:0045820),1/6,0.0053884659389882,0.0499609276067028,0,0,235.0235294117647,1227.644124299904,HDAC4
5,GO_Biological_Process_2018,activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171),1/6,0.0053884659389882,0.0499609276067028,0,0,235.0235294117647,1227.644124299904,NRG1
4,GO_Biological_Process_2018,negative regulation of coenzyme metabolic process (GO:0051198),1/6,0.0053884659389882,0.0499609276067028,0,0,235.0235294117647,1227.644124299904,HDAC4
3,GO_Biological_Process_2018,regulation of protein binding (GO:0043393),2/111,0.0044070373895657,0.0499609276067028,0,0,22.790137614678898,123.6263004577948,HDAC4;NRG1
2,GO_Biological_Process_2018,ERBB signaling pathway (GO:0038127),2/80,0.0023190473995785,0.0499609276067028,0,0,31.897435897435894,193.50894574053115,ERBIN;NRG1
43,GO_Biological_Process_2018,positive regulation of striated muscle cell differentiation (GO:0051155),1/17,0.0151962391911868,0.0499609276067028,0,0,73.40441176470588,307.3227868353231,NRG1
42,GO_Biological_Process_2018,nucleotide catabolic process (GO:0009166),1/17,0.0151962391911868,0.0499609276067028,0,0,73.40441176470588,307.3227868353231,GDA
41,GO_Biological_Process_2018,negative regulation of cellular carbohydrate metabolic process (GO:0010677),1/17,0.0151962391911868,0.0499609276067028,0,0,73.40441176470588,307.3227868353231,HDAC4
40,GO_Biological_Process_2018,regulation of protein sumoylation (GO:0033233),1/17,0.0151962391911868,0.0499609276067028,0,0,73.40441176470588,307.3227868353231,HDAC4
20,GO_Biological_Process_2018,negative regulation of myotube differentiation (GO:0010832),1/11,0.0098579216348164,0.0499609276067028,0,0,117.48235294117649,542.7073703814344,HDAC4
21,GO_Biological_Process_2018,purine nucleobase metabolic process (GO:0006144),1/11,0.0098579216348164,0.0499609276067028,0,0,117.48235294117649,542.7073703814344,GDA
22,GO_Biological_Process_2018,negative regulation of ATP metabolic process (GO:1903579),1/12,0.0107495345067081,0.0499609276067028,0,0,106.79679144385028,484.0984098875249,HDAC4
23,GO_Biological_Process_2018,histone H3 deacetylation (GO:0070932),1/12,0.0107495345067081,0.0499609276067028,0,0,106.79679144385028,484.0984098875249,HDAC4
24,GO_Biological_Process_2018,cardiocyte differentiation (GO:0035051),1/13,0.011640389286531,0.0499609276067028,0,0,97.8921568627451,435.94063546940737,NRG1
25,GO_Biological_Process_2018,regulation of secretion (GO:0051046),1/14,0.0125304865571366,0.0499609276067028,0,0,90.3574660633484,395.7287161899813,NRG1
26,GO_Biological_Process_2018,stem cell development (GO:0048864),1/14,0.0125304865571366,0.0499609276067028,0,0,90.3574660633484,395.7287161899813,NRG1
27,GO_Biological_Process_2018,purine-containing compound catabolic process (GO:0072523),1/14,0.0125304865571366,0.0499609276067028,0,0,90.3574660633484,395.7287161899813,GDA
28,GO_Biological_Process_2018,negative regulation of secretion (GO:0051048),1/14,0.0125304865571366,0.0499609276067028,0,0,90.3574660633484,395.7287161899813,NRG1
18,GO_Biological_Process_2018,presynaptic membrane assembly (GO:0097105),1/10,0.0089655500933473,0.0499609276067028,0,0,130.54248366013073,615.425022203049,PTPRD
29,GO_Biological_Process_2018,purine nucleotide catabolic process (GO:0006195),1/14,0.0125304865571366,0.0499609276067028,0,0,90.3574660633484,395.7287161899813,GDA
31,GO_Biological_Process_2018,presynapse assembly (GO:0099054),1/15,0.01341982690512,0.0499609276067028,0,0,83.89915966386555,361.6911269349327,PTPRD
17,GO_Biological_Process_2018,response to muramyl dipeptide (GO:0032495),1/9,0.0080724193100501,0.0499609276067028,0,0,146.86764705882354,707.7995527019895,ERBIN
33,GO_Biological_Process_2018,mesenchymal cell development (GO:0014031),1/15,0.01341982690512,0.0499609276067028,0,0,83.89915966386555,361.6911269349327,NRG1
34,GO_Biological_Process_2018,regulation of protein homodimerization activity (GO:0043496),1/16,0.0143084109196949,0.0499609276067028,0,0,78.30196078431372,332.5412031884909,NRG1
35,GO_Biological_Process_2018,protein deacylation (GO:0035601),1/16,0.0143084109196949,0.0499609276067028,0,0,78.30196078431372,332.5412031884909,HDAC4
36,GO_Biological_Process_2018,negative regulation of striated muscle cell differentiation (GO:0051154),1/16,0.0143084109196949,0.0499609276067028,0,0,78.30196078431372,332.5412031884909,HDAC4
37,GO_Biological_Process_2018,positive regulation of dendrite morphogenesis (GO:0050775),1/16,0.0143084109196949,0.0499609276067028,0,0,78.30196078431372,332.5412031884909,PTPRD
38,GO_Biological_Process_2018,odontogenesis of dentin-containing tooth (GO:0042475),1/16,0.0143084109196949,0.0499609276067028,0,0,78.30196078431372,332.5412031884909,ANKRD11
39,GO_Biological_Process_2018,myoblast differentiation (GO:0045445),1/16,0.0143084109196949,0.0499609276067028,0,0,78.30196078431372,332.5412031884909,NRG1
30,GO_Biological_Process_2018,neural crest cell differentiation (GO:0014033),1/15,0.01341982690512,0.0499609276067028,0,0,83.89915966386555,361.6911269349327,NRG1
32,GO_Biological_Process_2018,cardiac muscle cell differentiation (GO:0055007),1/15,0.01341982690512,0.0499609276067028,0,0,83.89915966386555,361.6911269349327,NRG1
199,GO_Biological_Process_2017b,ERBB2-EGFR signaling pathway (GO:0038134),2/73,0.0019358238702516,0.050103676641808,0,0,35.054577464788736,218.9937370166489,ERBIN;NRG1
47,GO_Biological_Process_2018,striated muscle cell differentiation (GO:0051146),1/19,0.01696963087688,0.0505625736331526,0,0,65.24183006535948,265.9472259849427,NRG1
48,GO_Biological_Process_2018,regulation of myotube differentiation (GO:0010830),1/19,0.01696963087688,0.0505625736331526,0,0,65.24183006535948,265.9472259849427,HDAC4
165,WikiPathways_2019_Human,Genes targeted by miRNAs in adipocytes WP1992,1/13,0.011640389286531,0.0512177128607366,0,0,97.8921568627451,435.94063546940737,HDAC4
164,WikiPathways_2019_Human,Nucleotide GPCRs WP80,1/11,0.0098579216348164,0.0512177128607366,0,0,117.48235294117649,542.7073703814344,ADORA1
163,WikiPathways_2019_Human,NLR Proteins WP288,1/9,0.0080724193100501,0.0512177128607366,0,0,146.86764705882354,707.7995527019895,ERBIN
49,GO_Biological_Process_2018,purine nucleotide metabolic process (GO:0006163),1/20,0.0178551954764704,0.0521371707912936,0,0,61.80495356037152,248.79341471282052,GDA
50,GO_Biological_Process_2018,regulation of ERBB signaling pathway (GO:1901184),1/22,0.0196240651712844,0.0561786963726965,0,0,55.91316526610644,219.7945772360195,NRG1
51,GO_Biological_Process_2018,membrane assembly (GO:0071709),1/23,0.0205073714570783,0.0575783890910277,0,0,53.36898395721925,207.44368622737056,PTPRD
52,GO_Biological_Process_2018,inflammatory response (GO:0006954),2/252,0.0211844439649737,0.0578320225746209,0,0,9.866,38.02838000784799,HDAC4;ADORA1
53,GO_Biological_Process_2018,mammary gland development (GO:0030879),1/24,0.0213899261577365,0.0578320225746209,0,0,51.0460358056266,196.26359569838613,NRG1
245,GO_Biological_Process_2017b,histone H3-K56 deacetylation (GO:0071572),1/12,0.0107495345067081,0.0601170263674046,0,0,106.79679144385028,484.0984098875249,HDAC4
232,GO_Biological_Process_2017b,His-Purkinje system cell differentiation (GO:0060932),1/11,0.0098579216348164,0.0601170263674046,0,0,117.48235294117649,542.7073703814344,NRG1
231,GO_Biological_Process_2017b,cardiac neural crest cell development involved in heart development (GO:0061308),1/11,0.0098579216348164,0.0601170263674046,0,0,117.48235294117649,542.7073703814344,NRG1
227,GO_Biological_Process_2017b,cardiac pacemaker cell differentiation (GO:0060920),1/11,0.0098579216348164,0.0601170263674046,0,0,117.48235294117649,542.7073703814344,NRG1
229,GO_Biological_Process_2017b,atrial cardiac muscle cell differentiation (GO:0055011),1/11,0.0098579216348164,0.0601170263674046,0,0,117.48235294117649,542.7073703814344,NRG1
228,GO_Biological_Process_2017b,negative regulation of skeletal muscle fiber differentiation (GO:1902810),1/11,0.0098579216348164,0.0601170263674046,0,0,117.48235294117649,542.7073703814344,HDAC4
233,GO_Biological_Process_2017b,protein deacetylation (GO:0006476),1/11,0.0098579216348164,0.0601170263674046,0,0,117.48235294117649,542.7073703814344,HDAC4
226,GO_Biological_Process_2017b,regulation of heparan sulfate proteoglycan binding (GO:1905858),1/11,0.0098579216348164,0.0601170263674046,0,0,117.48235294117649,542.7073703814344,HDAC4
230,GO_Biological_Process_2017b,regulation of apolipoprotein binding (GO:2000656),1/11,0.0098579216348164,0.0601170263674046,0,0,117.48235294117649,542.7073703814344,HDAC4
234,GO_Biological_Process_2017b,positive regulation of myotube differentiation (GO:0010831),1/11,0.0098579216348164,0.0601170263674046,0,0,117.48235294117649,542.7073703814344,NRG1
238,GO_Biological_Process_2017b,regulation of collagen binding (GO:0033341),1/11,0.0098579216348164,0.0601170263674046,0,0,117.48235294117649,542.7073703814344,HDAC4
236,GO_Biological_Process_2017b,Hsp90 deacetylation (GO:0070846),1/11,0.0098579216348164,0.0601170263674046,0,0,117.48235294117649,542.7073703814344,HDAC4
237,GO_Biological_Process_2017b,regulation of actin binding (GO:1904616),1/11,0.0098579216348164,0.0601170263674046,0,0,117.48235294117649,542.7073703814344,HDAC4
225,GO_Biological_Process_2017b,regulation of C-C chemokine binding (GO:2001263),1/11,0.0098579216348164,0.0601170263674046,0,0,117.48235294117649,542.7073703814344,HDAC4
239,GO_Biological_Process_2017b,regulation of protein binding (GO:0043393),1/11,0.0098579216348164,0.0601170263674046,0,0,117.48235294117649,542.7073703814344,HDAC4
240,GO_Biological_Process_2017b,histone H3-K4 deacetylation (GO:1990596),1/12,0.0107495345067081,0.0601170263674046,0,0,106.79679144385028,484.0984098875249,HDAC4
241,GO_Biological_Process_2017b,regulation of microtubule binding (GO:1904526),1/12,0.0107495345067081,0.0601170263674046,0,0,106.79679144385028,484.0984098875249,HDAC4
242,GO_Biological_Process_2017b,ventricular cardiac muscle cell differentiation (GO:0055012),1/12,0.0107495345067081,0.0601170263674046,0,0,106.79679144385028,484.0984098875249,NRG1
243,GO_Biological_Process_2017b,cardiac muscle cell myoblast differentiation (GO:0060379),1/12,0.0107495345067081,0.0601170263674046,0,0,106.79679144385028,484.0984098875249,NRG1
244,GO_Biological_Process_2017b,histone H3-K9 deacetylation (GO:1990619),1/12,0.0107495345067081,0.0601170263674046,0,0,106.79679144385028,484.0984098875249,HDAC4
246,GO_Biological_Process_2017b,mammary gland morphogenesis (GO:0060443),1/12,0.0107495345067081,0.0601170263674046,0,0,106.79679144385028,484.0984098875249,NRG1
247,GO_Biological_Process_2017b,negative regulation of myoblast fusion (GO:1901740),1/13,0.011640389286531,0.0601170263674046,0,0,97.8921568627451,435.94063546940737,HDAC4
248,GO_Biological_Process_2017b,negative regulation of skeletal muscle fiber development (GO:0048744),1/13,0.011640389286531,0.0601170263674046,0,0,97.8921568627451,435.94063546940737,HDAC4
235,GO_Biological_Process_2017b,regulation of receptor binding (GO:1900120),1/11,0.0098579216348164,0.0601170263674046,0,0,117.48235294117649,542.7073703814344,HDAC4
224,GO_Biological_Process_2017b,tubulin deacetylation (GO:0090042),1/11,0.0098579216348164,0.0601170263674046,0,0,117.48235294117649,542.7073703814344,HDAC4
219,GO_Biological_Process_2017b,left ventricular trabecular myocardium morphogenesis (GO:0003225),1/10,0.0089655500933473,0.0601170263674046,0,0,130.54248366013073,615.425022203049,NRG1
222,GO_Biological_Process_2017b,thelarche (GO:0042695),1/10,0.0089655500933473,0.0601170263674046,0,0,130.54248366013073,615.425022203049,NRG1
200,GO_Biological_Process_2017b,negative regulation of NF-kappaB transcription factor activity (GO:0032088),2/115,0.0047218279585048,0.0601170263674046,0,0,21.978982300884955,117.70974251686668,HDAC4;ERBIN
201,GO_Biological_Process_2017b,negative regulation of gastric acid secretion (GO:0060455),1/6,0.0053884659389882,0.0601170263674046,0,0,235.0235294117647,1227.644124299904,NRG1
202,GO_Biological_Process_2017b,negative regulation of dehydroepiandrosterone secretion (GO:2000841),1/7,0.0062838777740325,0.0601170263674046,0,0,195.843137254902,992.8792720611536,NRG1
203,GO_Biological_Process_2017b,negative regulation of androstenedione secretion (GO:2000838),1/7,0.0062838777740325,0.0601170263674046,0,0,195.843137254902,992.8792720611536,NRG1
204,GO_Biological_Process_2017b,negative regulation of estrone secretion (GO:2000868),1/7,0.0062838777740325,0.0601170263674046,0,0,195.843137254902,992.8792720611536,NRG1
205,GO_Biological_Process_2017b,negative regulation of estradiol secretion (GO:2000865),1/7,0.0062838777740325,0.0601170263674046,0,0,195.843137254902,992.8792720611536,NRG1
206,GO_Biological_Process_2017b,negative regulation of testosterone secretion (GO:2000844),1/7,0.0062838777740325,0.0601170263674046,0,0,195.843137254902,992.8792720611536,NRG1
207,GO_Biological_Process_2017b,negative regulation of renal sodium excretion (GO:0035814),1/7,0.0062838777740325,0.0601170263674046,0,0,195.843137254902,992.8792720611536,NRG1
208,GO_Biological_Process_2017b,negative regulation of saliva secretion (GO:1905747),1/8,0.0071785287204102,0.0601170263674046,0,0,167.85714285714286,828.6537822644398,NRG1
209,GO_Biological_Process_2017b,cardiac muscle hypertrophy in response to stress (GO:0014898),1/8,0.0071785287204102,0.0601170263674046,0,0,167.85714285714286,828.6537822644398,HDAC4
223,GO_Biological_Process_2017b,regulation of Ras GTPase binding (GO:1904475),1/11,0.0098579216348164,0.0601170263674046,0,0,117.48235294117649,542.7073703814344,HDAC4
210,GO_Biological_Process_2017b,cellular response to muramyl dipeptide (GO:0071225),1/8,0.0071785287204102,0.0601170263674046,0,0,167.85714285714286,828.6537822644398,ERBIN
212,GO_Biological_Process_2017b,positive regulation of cardiac muscle cell differentiation (GO:2000727),1/8,0.0071785287204102,0.0601170263674046,0,0,167.85714285714286,828.6537822644398,NRG1
213,GO_Biological_Process_2017b,negative regulation of secretion (GO:0051048),1/8,0.0071785287204102,0.0601170263674046,0,0,167.85714285714286,828.6537822644398,NRG1
214,GO_Biological_Process_2017b,histone H4-K12 deacetylation (GO:1990679),1/8,0.0071785287204102,0.0601170263674046,0,0,167.85714285714286,828.6537822644398,HDAC4
215,GO_Biological_Process_2017b,positive regulation of protein sumoylation (GO:0033235),1/9,0.0080724193100501,0.0601170263674046,0,0,146.86764705882354,707.7995527019895,HDAC4
216,GO_Biological_Process_2017b,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),1/9,0.0080724193100501,0.0601170263674046,0,0,146.86764705882354,707.7995527019895,ERBIN
217,GO_Biological_Process_2017b,right ventricular trabecular myocardium morphogenesis (GO:0003227),1/10,0.0089655500933473,0.0601170263674046,0,0,130.54248366013073,615.425022203049,NRG1
218,GO_Biological_Process_2017b,bone trabecula formation (GO:0060346),1/10,0.0089655500933473,0.0601170263674046,0,0,130.54248366013073,615.425022203049,ANKRD11
249,GO_Biological_Process_2017b,transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),1/13,0.011640389286531,0.0601170263674046,0,0,97.8921568627451,435.94063546940737,PTPRD
220,GO_Biological_Process_2017b,mammary gland development (GO:0030879),1/10,0.0089655500933473,0.0601170263674046,0,0,130.54248366013073,615.425022203049,NRG1
221,GO_Biological_Process_2017b,positive regulation of SUMO transferase activity (GO:1903755),1/10,0.0089655500933473,0.0601170263674046,0,0,130.54248366013073,615.425022203049,HDAC4
211,GO_Biological_Process_2017b,histone H4-K16 deacetylation (GO:1990678),1/8,0.0071785287204102,0.0601170263674046,0,0,167.85714285714286,828.6537822644398,HDAC4
250,GO_Biological_Process_2017b,cardiac muscle cell development (GO:0055013),1/13,0.011640389286531,0.0601170263674046,0,0,97.8921568627451,435.94063546940737,NRG1
278,GO_Biological_Process_2017b,O3-(N-acetylglucosamine-1-phosphoryl)-L-serine biosynthetic process (GO:0018425),1/16,0.0143084109196949,0.0601170263674046,0,0,78.30196078431372,332.5412031884909,PTPRD
252,GO_Biological_Process_2017b,dosage compensation (GO:0007549),1/13,0.011640389286531,0.0601170263674046,0,0,97.8921568627451,435.94063546940737,HDAC4
275,GO_Biological_Process_2017b,dentin secretion (GO:0070468),1/16,0.0143084109196949,0.0601170263674046,0,0,78.30196078431372,332.5412031884909,ANKRD11
276,GO_Biological_Process_2017b,1-deoxy-D-xylulose 5-phosphate metabolic process (GO:0052863),1/16,0.0143084109196949,0.0601170263674046,0,0,78.30196078431372,332.5412031884909,PTPRD
277,GO_Biological_Process_2017b,6-sulfoquinovose(1-) catabolic process to glycerone phosphate and 3-sulfolactaldehyde (GO:0061720),1/16,0.0143084109196949,0.0601170263674046,0,0,78.30196078431372,332.5412031884909,PTPRD
279,GO_Biological_Process_2017b,methanopterin-containing compound metabolic process (GO:2001115),1/16,0.0143084109196949,0.0601170263674046,0,0,78.30196078431372,332.5412031884909,PTPRD
280,GO_Biological_Process_2017b,carbamoyl phosphate metabolic process (GO:0070408),1/16,0.0143084109196949,0.0601170263674046,0,0,78.30196078431372,332.5412031884909,PTPRD
281,GO_Biological_Process_2017b,alditol phosphate metabolic process (GO:0052646),1/16,0.0143084109196949,0.0601170263674046,0,0,78.30196078431372,332.5412031884909,PTPRD
282,GO_Biological_Process_2017b,presynaptic membrane assembly (GO:0097105),1/16,0.0143084109196949,0.0601170263674046,0,0,78.30196078431372,332.5412031884909,PTPRD
283,GO_Biological_Process_2017b,phosphagen metabolic process (GO:0006599),1/16,0.0143084109196949,0.0601170263674046,0,0,78.30196078431372,332.5412031884909,PTPRD
251,GO_Biological_Process_2017b,negative regulation of myotube differentiation (GO:0010832),1/13,0.011640389286531,0.0601170263674046,0,0,97.8921568627451,435.94063546940737,HDAC4
285,GO_Biological_Process_2017b,chronic inflammatory response (GO:0002544),2/211,0.0151661891266679,0.0601170263674046,0,0,11.825956937799043,49.53522887531236,HDAC4;ADORA1
286,GO_Biological_Process_2017b,inflammatory response (GO:0006954),2/211,0.0151661891266679,0.0601170263674046,0,0,11.825956937799043,49.53522887531236,HDAC4;ADORA1
287,GO_Biological_Process_2017b,thiamine diphosphate metabolic process (GO:0042357),1/17,0.0151962391911868,0.0601170263674046,0,0,73.40441176470588,307.3227868353231,PTPRD
288,GO_Biological_Process_2017b,molybdopterin cofactor metabolic process (GO:0043545),1/17,0.0151962391911868,0.0601170263674046,0,0,73.40441176470588,307.3227868353231,PTPRD
289,GO_Biological_Process_2017b,B cell activation involved in immune response (GO:0002312),1/17,0.0151962391911868,0.0601170263674046,0,0,73.40441176470588,307.3227868353231,HDAC4
290,GO_Biological_Process_2017b,L-methionine biosynthetic process from O-phospho-L-homoserine and cystathionine (GO:0019283),1/17,0.0151962391911868,0.0601170263674046,0,0,73.40441176470588,307.3227868353231,PTPRD
291,GO_Biological_Process_2017b,mammary gland epithelium development (GO:0061180),1/17,0.0151962391911868,0.0601170263674046,0,0,73.40441176470588,307.3227868353231,NRG1
292,GO_Biological_Process_2017b,lipid X metabolic process (GO:2001289),1/17,0.0151962391911868,0.0601170263674046,0,0,73.40441176470588,307.3227868353231,PTPRD
293,GO_Biological_Process_2017b,mammary gland fat development (GO:0060611),1/17,0.0151962391911868,0.0601170263674046,0,0,73.40441176470588,307.3227868353231,NRG1
294,GO_Biological_Process_2017b,acute inflammatory response (GO:0002526),2/212,0.015302515802612,0.0601170263674046,0,0,11.76904761904762,49.19153594031784,HDAC4;ADORA1
274,GO_Biological_Process_2017b,glucose 1-phosphate metabolic process (GO:0019255),1/16,0.0143084109196949,0.0601170263674046,0,0,78.30196078431372,332.5412031884909,PTPRD
273,GO_Biological_Process_2017b,glyceraldehyde-3-phosphate metabolic process (GO:0019682),1/16,0.0143084109196949,0.0601170263674046,0,0,78.30196078431372,332.5412031884909,PTPRD
284,GO_Biological_Process_2017b,inflammatory response to wounding (GO:0090594),2/211,0.0151661891266679,0.0601170263674046,0,0,11.825956937799043,49.53522887531236,HDAC4;ADORA1
271,GO_Biological_Process_2017b,D-glycero-D-manno-heptose 7-phosphate metabolic process (GO:2001060),1/16,0.0143084109196949,0.0601170263674046,0,0,78.30196078431372,332.5412031884909,PTPRD
255,GO_Biological_Process_2017b,purine ribonucleotide catabolic process (GO:0009154),1/14,0.0125304865571366,0.0601170263674046,0,0,90.3574660633484,395.7287161899813,GDA
256,GO_Biological_Process_2017b,purine deoxyribonucleotide catabolic process (GO:0009155),1/15,0.01341982690512,0.0601170263674046,0,0,83.89915966386555,361.6911269349327,GDA
257,GO_Biological_Process_2017b,B cell activation (GO:0042113),1/15,0.01341982690512,0.0601170263674046,0,0,83.89915966386555,361.6911269349327,HDAC4
258,GO_Biological_Process_2017b,response to muramyl dipeptide (GO:0032495),1/15,0.01341982690512,0.0601170263674046,0,0,83.89915966386555,361.6911269349327,ERBIN
259,GO_Biological_Process_2017b,purine nucleotide catabolic process (GO:0006195),1/15,0.01341982690512,0.0601170263674046,0,0,83.89915966386555,361.6911269349327,GDA
260,GO_Biological_Process_2017b,establishment of B cell polarity (GO:0001769),1/15,0.01341982690512,0.0601170263674046,0,0,83.89915966386555,361.6911269349327,HDAC4
261,GO_Biological_Process_2017b,mesenchymal cell differentiation involved in mammary gland development (GO:0060610),1/15,0.01341982690512,0.0601170263674046,0,0,83.89915966386555,361.6911269349327,NRG1
262,GO_Biological_Process_2017b,peptidyl-lysine deacetylation (GO:0034983),1/15,0.01341982690512,0.0601170263674046,0,0,83.89915966386555,361.6911269349327,HDAC4
254,GO_Biological_Process_2017b,negative regulation of ERBB3 signaling pathway (GO:1905579),1/14,0.0125304865571366,0.0601170263674046,0,0,90.3574660633484,395.7287161899813,NRG1
272,GO_Biological_Process_2017b,"cyclic 2,3-bisphospho-D-glycerate biosynthetic process (GO:1901369)",1/16,0.0143084109196949,0.0601170263674046,0,0,78.30196078431372,332.5412031884909,PTPRD
263,GO_Biological_Process_2017b,ribose phosphate metabolic process (GO:0019693),1/16,0.0143084109196949,0.0601170263674046,0,0,78.30196078431372,332.5412031884909,PTPRD
264,GO_Biological_Process_2017b,6-sulfoquinovose(1-) catabolic process to 3-sulfopropanediol(1-) (GO:0061721),1/16,0.0143084109196949,0.0601170263674046,0,0,78.30196078431372,332.5412031884909,PTPRD
265,GO_Biological_Process_2017b,tooth placode formation (GO:0060790),1/16,0.0143084109196949,0.0601170263674046,0,0,78.30196078431372,332.5412031884909,ANKRD11
266,GO_Biological_Process_2017b,nucleoside phosphate metabolic process (GO:0006753),1/16,0.0143084109196949,0.0601170263674046,0,0,78.30196078431372,332.5412031884909,PTPRD
267,GO_Biological_Process_2017b,D-tagatose 6-phosphate metabolic process (GO:2001058),1/16,0.0143084109196949,0.0601170263674046,0,0,78.30196078431372,332.5412031884909,PTPRD
268,GO_Biological_Process_2017b,xylulose 5-phosphate metabolic process (GO:0051167),1/16,0.0143084109196949,0.0601170263674046,0,0,78.30196078431372,332.5412031884909,PTPRD
269,GO_Biological_Process_2017b,phosphate-containing compound metabolic process (GO:0006796),1/16,0.0143084109196949,0.0601170263674046,0,0,78.30196078431372,332.5412031884909,PTPRD
270,GO_Biological_Process_2017b,deoxyribose phosphate metabolic process (GO:0019692),1/16,0.0143084109196949,0.0601170263674046,0,0,78.30196078431372,332.5412031884909,PTPRD
253,GO_Biological_Process_2017b,positive regulation of sarcomere organization (GO:0060298),1/14,0.0125304865571366,0.0601170263674046,0,0,90.3574660633484,395.7287161899813,NRG1
298,GO_Biological_Process_2017b,cardiac muscle cell fate commitment (GO:0060923),1/18,0.0160833123117468,0.0610056673893844,0,0,69.08304498269896,285.3111137768628,NRG1
295,GO_Biological_Process_2017b,"7,8-dihydroneopterin 3'-triphosphate biosynthetic process (GO:0035998)",1/18,0.0160833123117468,0.0610056673893844,0,0,69.08304498269896,285.3111137768628,PTPRD
297,GO_Biological_Process_2017b,"fructose 2,6-bisphosphate metabolic process (GO:0006003)",1/18,0.0160833123117468,0.0610056673893844,0,0,69.08304498269896,285.3111137768628,PTPRD
296,GO_Biological_Process_2017b,maintenance of epithelial cell apical/basal polarity (GO:0045199),1/18,0.0160833123117468,0.0610056673893844,0,0,69.08304498269896,285.3111137768628,ERBIN
54,GO_Biological_Process_2018,positive regulation of synapse assembly (GO:0051965),1/26,0.0231527832149216,0.0614601154432465,0,0,46.95764705882353,176.82560723797164,PTPRD
299,GO_Biological_Process_2017b,pyridoxal phosphate metabolic process (GO:0042822),1/19,0.01696963087688,0.0632765897104,0,0,65.24183006535948,265.9472259849427,PTPRD
300,GO_Biological_Process_2017b,GDP-mannose biosynthetic process from fructose-6-phosphate (GO:0061729),1/19,0.01696963087688,0.0632765897104,0,0,65.24183006535948,265.9472259849427,PTPRD
301,GO_Biological_Process_2017b,establishment of epithelial cell apical/basal polarity (GO:0045198),1/20,0.0178551954764704,0.0649279835508015,0,0,61.80495356037152,248.79341471282052,ERBIN
302,GO_Biological_Process_2017b,regulation of gene expression by genetic imprinting (GO:0006349),1/20,0.0178551954764704,0.0649279835508015,0,0,61.80495356037152,248.79341471282052,HDAC4
303,GO_Biological_Process_2017b,glucose 6-phosphate metabolic process (GO:0051156),1/20,0.0178551954764704,0.0649279835508015,0,0,61.80495356037152,248.79341471282052,PTPRD
306,GO_Biological_Process_2017b,tyrosine catabolic process to phosphoenolpyruvate (GO:0019446),1/21,0.0187400067082949,0.0664967979971755,0,0,58.71176470588235,233.50224496360525,PTPRD
305,GO_Biological_Process_2017b,cardiac muscle cell differentiation (GO:0055007),1/21,0.0187400067082949,0.0664967979971755,0,0,58.71176470588235,233.50224496360525,NRG1
304,GO_Biological_Process_2017b,neural crest cell development (GO:0014032),1/21,0.0187400067082949,0.0664967979971755,0,0,58.71176470588235,233.50224496360525,NRG1
308,GO_Biological_Process_2017b,fructose 6-phosphate metabolic process (GO:0006002),1/22,0.0196240651712844,0.068528481550517,0,0,55.91316526610644,219.7945772360195,PTPRD
307,GO_Biological_Process_2017b,neural crest cell migration (GO:0001755),1/22,0.0196240651712844,0.068528481550517,0,0,55.91316526610644,219.7945772360195,NRG1
55,GO_Biological_Process_2018,activation of protein kinase B activity (GO:0032148),1/30,0.0266695046006179,0.0695312084230396,0,0,40.47261663286004,146.68225415832842,NRG1
62,GO_Biological_Process_2018,response to peptide (GO:1901652),1/34,0.030174267482518,0.0695617575207106,0,0,35.559714795008915,124.48623298308226,ERBIN
57,GO_Biological_Process_2018,protein deacetylation (GO:0006476),1/32,0.0284233784701102,0.0695617575207106,0,0,37.85768500948767,134.79392621731594,HDAC4
65,GO_Biological_Process_2018,histone deacetylation (GO:0016575),1/36,0.0319221763964905,0.0695617575207106,0,0,33.52436974789916,115.4731604004656,HDAC4
58,GO_Biological_Process_2018,positive regulation of dendrite development (GO:1900006),1/32,0.0284233784701102,0.0695617575207106,0,0,37.85768500948767,134.79392621731594,PTPRD
59,GO_Biological_Process_2018,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),1/33,0.0292991957903235,0.0695617575207106,0,0,36.67279411764706,129.4621221594897,ERBIN
60,GO_Biological_Process_2018,positive regulation of muscle cell differentiation (GO:0051149),1/34,0.030174267482518,0.0695617575207106,0,0,35.559714795008915,124.48623298308226,NRG1
61,GO_Biological_Process_2018,ventricular cardiac muscle tissue morphogenesis (GO:0055010),1/34,0.030174267482518,0.0695617575207106,0,0,35.559714795008915,124.48623298308226,NRG1
64,GO_Biological_Process_2018,neural crest cell development (GO:0014032),1/35,0.0310485941558708,0.0695617575207106,0,0,34.5121107266436,119.83301120641356,NRG1
63,GO_Biological_Process_2018,regulation of synapse assembly (GO:0051963),1/35,0.0310485941558708,0.0695617575207106,0,0,34.5121107266436,119.83301120641356,PTPRD
56,GO_Biological_Process_2018,skeletal system morphogenesis (GO:0048705),1/31,0.0275468149406694,0.0695617575207106,0,0,39.12156862745098,140.51952455455398,ANKRD11
66,GO_Biological_Process_2018,cardiac muscle tissue development (GO:0048738),1/36,0.0319221763964905,0.0695617575207106,0,0,33.52436974789916,115.4731604004656,NRG1
309,GO_Biological_Process_2017b,glycerol to glycerone phosphate metabolic process (GO:0061610),1/23,0.0205073714570783,0.0704940893837068,0,0,53.36898395721925,207.44368622737056,PTPRD
310,GO_Biological_Process_2017b,"fructose 1,6-bisphosphate metabolic process (GO:0030388)",1/23,0.0205073714570783,0.0704940893837068,0,0,53.36898395721925,207.44368622737056,PTPRD
311,GO_Biological_Process_2017b,lactation (GO:0007595),1/24,0.0213899261577365,0.0729578876697989,0,0,51.0460358056266,196.26359569838613,NRG1
312,GO_Biological_Process_2017b,neurexin clustering involved in presynaptic membrane assembly (GO:0097115),1/25,0.0222717298790694,0.0743593037559527,0,0,48.91666666666666,186.10038260880103,PTPRD
319,GO_Biological_Process_2017b,regulation of flagellated sperm motility (GO:1901317),1/26,0.0231527832149216,0.0743593037559527,0,0,46.95764705882353,176.82560723797164,NRG1
318,GO_Biological_Process_2017b,histone deacetylation at centromere (GO:0031059),1/26,0.0231527832149216,0.0743593037559527,0,0,46.95764705882353,176.82560723797164,HDAC4
317,GO_Biological_Process_2017b,positive regulation of striated muscle cell differentiation (GO:0051155),1/26,0.0231527832149216,0.0743593037559527,0,0,46.95764705882353,176.82560723797164,NRG1
315,GO_Biological_Process_2017b,regulation of bacterial-type flagellum-dependent cell motility (GO:1902021),1/26,0.0231527832149216,0.0743593037559527,0,0,46.95764705882353,176.82560723797164,NRG1
314,GO_Biological_Process_2017b,regulation of cilium-dependent cell motility (GO:1902019),1/26,0.0231527832149216,0.0743593037559527,0,0,46.95764705882353,176.82560723797164,NRG1
313,GO_Biological_Process_2017b,regulation of amoeboid sperm motility (GO:1905416),1/26,0.0231527832149216,0.0743593037559527,0,0,46.95764705882353,176.82560723797164,NRG1
316,GO_Biological_Process_2017b,modulation by symbiont of host cell motility (GO:1903653),1/26,0.0231527832149216,0.0743593037559527,0,0,46.95764705882353,176.82560723797164,NRG1
68,GO_Biological_Process_2018,negative regulation of catabolic process (GO:0009895),1/40,0.035409072945574,0.0749235456529538,0,0,30.07993966817496,100.49067723322013,HDAC4
67,GO_Biological_Process_2018,negative regulation of transport (GO:0051051),1/40,0.035409072945574,0.0749235456529538,0,0,30.07993966817496,100.49067723322013,NRG1
69,GO_Biological_Process_2018,odontogenesis (GO:0042476),1/41,0.0362789419461595,0.0756675074877041,0,0,29.326470588235296,97.26176223664352,ANKRD11
320,GO_Biological_Process_2017b,regulation of cell motility (GO:2000145),1/27,0.0240330867565966,0.0760759580784353,0,0,45.14932126696833,168.33128827465845,NRG1
321,GO_Biological_Process_2017b,negative regulation of ERBB signaling pathway (GO:1901185),1/27,0.0240330867565966,0.0760759580784353,0,0,45.14932126696833,168.33128827465845,NRG1
70,GO_Biological_Process_2018,negative regulation of ERBB signaling pathway (GO:1901185),1/43,0.0380164579400951,0.0781746881585055,0,0,27.92717086834734,91.3144790197023,NRG1
322,GO_Biological_Process_2017b,negative regulation of glycolytic process (GO:0045820),1/28,0.0249126411012733,0.0782968720325732,0,0,43.474945533769066,160.52601632867996,HDAC4
71,GO_Biological_Process_2018,regulation of dendrite morphogenesis (GO:0048814),1/44,0.0388841061194349,0.078848326297743,0,0,27.276333789329687,88.57088446864675,PTPRD
324,GO_Biological_Process_2017b,positive regulation of dendrite morphogenesis (GO:0050775),1/29,0.02579144685281,0.0799171592622281,0,0,41.92016806722689,153.33191684558912,PTPRD
323,GO_Biological_Process_2017b,histone H4 deacetylation (GO:0070933),1/29,0.02579144685281,0.0799171592622281,0,0,41.92016806722689,153.33191684558912,HDAC4
72,GO_Biological_Process_2018,regulation of cellular component movement (GO:0051270),1/46,0.0406171857845244,0.0812343715690489,0,0,26.06143790849673,83.48948444789488,NRG1
326,GO_Biological_Process_2017b,embryonic skeletal system morphogenesis (GO:0048704),1/30,0.0266695046006179,0.0814901529463325,0,0,40.47261663286004,146.68225415832842,ANKRD11
325,GO_Biological_Process_2017b,phenylalanine catabolic process to phosphoenolpyruvate (GO:0019562),1/30,0.0266695046006179,0.0814901529463325,0,0,40.47261663286004,146.68225415832842,PTPRD
73,GO_Biological_Process_2018,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),1/47,0.0414826184608072,0.0818440850713223,0,0,25.493606138107417,81.1329113370927,PTPRD
327,GO_Biological_Process_2017b,ventricular trabecula myocardium morphogenesis (GO:0003222),1/31,0.0275468149406694,0.0835903349923763,0,0,39.12156862745098,140.51952455455398,NRG1
328,GO_Biological_Process_2017b,regulation of cell motility involved in somitogenic axis elongation (GO:0090249),1/32,0.0284233784701102,0.0850767790942075,0,0,37.85768500948767,134.79392621731594,NRG1
329,GO_Biological_Process_2017b,histone H3 deacetylation (GO:0070932),1/32,0.0284233784701102,0.0850767790942075,0,0,37.85768500948767,134.79392621731594,HDAC4
166,WikiPathways_2019_Human,Ethanol effects on histone modifications WP3996,1/31,0.0275468149406694,0.0855428776793611,0,0,39.12156862745098,140.51952455455398,HDAC4
167,WikiPathways_2019_Human,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,1/32,0.0284233784701102,0.0855428776793611,0,0,37.85768500948767,134.79392621731594,HDAC4
168,WikiPathways_2019_Human,Sleep regulation WP3591,1/38,0.0336671099659209,0.0855428776793611,0,0,31.70906200317965,107.5328454820737,ADORA1
169,WikiPathways_2019_Human,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,1/41,0.0362789419461595,0.0855428776793611,0,0,29.326470588235296,97.26176223664352,ERBIN
170,WikiPathways_2019_Human,ATM Signaling Network in Development and Disease  WP3878,1/45,0.0397510152021215,0.0855428776793611,0,0,26.655080213903744,85.9658295948253,HDAC4
171,WikiPathways_2019_Human,Cardiac Progenitor Differentiation WP2406,1/53,0.0466597514614696,0.0855428776793611,0,0,22.54524886877828,69.09833217880467,NRG1
172,WikiPathways_2019_Human,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,1/53,0.0466597514614696,0.0855428776793611,0,0,22.54524886877828,69.09833217880467,NRG1
74,GO_Biological_Process_2018,wound healing (GO:0042060),1/50,0.0440744949316926,0.085798350133695,0,0,23.92917166866747,74.70385911458476,NRG1
350,GO_Biological_Process_2017b,positive regulation of chorionic trophoblast cell proliferation (GO:1901384),2/328,0.0345076258272867,0.0867083974562781,0,0,7.53680981595092,25.37323506069553,HDAC4;NRG1
351,GO_Biological_Process_2017b,positive regulation of hair follicle cell proliferation (GO:0071338),2/328,0.0345076258272867,0.0867083974562781,0,0,7.53680981595092,25.37323506069553,HDAC4;NRG1
352,GO_Biological_Process_2017b,positive regulation of fat cell proliferation (GO:0070346),2/328,0.0345076258272867,0.0867083974562781,0,0,7.53680981595092,25.37323506069553,HDAC4;NRG1
353,GO_Biological_Process_2017b,negative regulation of cell motility (GO:2000146),1/39,0.0345384624837867,0.0867083974562781,0,0,30.87306501547988,103.9089106040704,NRG1
354,GO_Biological_Process_2017b,positive regulation of mesenchymal cell proliferation (GO:0002053),2/329,0.0347003561391464,0.0867083974562781,0,0,7.513379204892966,25.2525075442342,HDAC4;NRG1
355,GO_Biological_Process_2017b,positive regulation of cell proliferation involved in heart morphogenesis (GO:2000138),2/329,0.0347003561391464,0.0867083974562781,0,0,7.513379204892966,25.2525075442342,HDAC4;NRG1
359,GO_Biological_Process_2017b,positive regulation of myoblast proliferation (GO:2000288),2/330,0.0348935168040023,0.0867083974562781,0,0,7.490091463414634,25.132659098670835,HDAC4;NRG1
357,GO_Biological_Process_2017b,positive regulation of chondrocyte proliferation (GO:1902732),2/330,0.0348935168040023,0.0867083974562781,0,0,7.490091463414634,25.132659098670835,HDAC4;NRG1
358,GO_Biological_Process_2017b,positive regulation of cell proliferation involved in kidney development (GO:1901724),2/330,0.0348935168040023,0.0867083974562781,0,0,7.490091463414634,25.132659098670835,HDAC4;NRG1
349,GO_Biological_Process_2017b,positive regulation of hemocyte proliferation (GO:0035208),2/328,0.0345076258272867,0.0867083974562781,0,0,7.53680981595092,25.37323506069553,HDAC4;NRG1
360,GO_Biological_Process_2017b,positive regulation of cardiac muscle cell proliferation (GO:0060045),2/334,0.0356704463010588,0.0867083974562781,0,0,7.398343373493976,24.661880228235027,HDAC4;NRG1
361,GO_Biological_Process_2017b,positive regulation of stem cell proliferation (GO:2000648),2/334,0.0356704463010588,0.0867083974562781,0,0,7.398343373493976,24.661880228235027,HDAC4;NRG1
362,GO_Biological_Process_2017b,positive regulation of trophectodermal cell proliferation (GO:1904075),2/335,0.0358657462205514,0.0867083974562781,0,0,7.3757507507507505,24.546296279366704,HDAC4;NRG1
363,GO_Biological_Process_2017b,positive regulation of neural precursor cell proliferation (GO:2000179),2/335,0.0358657462205514,0.0867083974562781,0,0,7.3757507507507505,24.546296279366704,HDAC4;NRG1
356,GO_Biological_Process_2017b,positive regulation of glial cell proliferation (GO:0060252),2/330,0.0348935168040023,0.0867083974562781,0,0,7.490091463414634,25.132659098670835,HDAC4;NRG1
348,GO_Biological_Process_2017b,positive regulation of secondary heart field cardioblast proliferation (GO:0072513),2/328,0.0345076258272867,0.0867083974562781,0,0,7.53680981595092,25.37323506069553,HDAC4;NRG1
344,GO_Biological_Process_2017b,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway (GO:0038091),2/327,0.0343153267032211,0.0867083974562781,0,0,7.560384615384615,25.494850641420424,HDAC4;NRG1
346,GO_Biological_Process_2017b,positive regulation of leukocyte proliferation (GO:0070665),2/327,0.0343153267032211,0.0867083974562781,0,0,7.560384615384615,25.494850641420424,HDAC4;NRG1
330,GO_Biological_Process_2017b,apoptotic cell clearance (GO:0043277),1/34,0.030174267482518,0.0867083974562781,0,0,35.559714795008915,124.48623298308226,ADORA1
364,GO_Biological_Process_2017b,positive regulation of osteoblast proliferation (GO:0033690),2/335,0.0358657462205514,0.0867083974562781,0,0,7.3757507507507505,24.546296279366704,HDAC4;NRG1
341,GO_Biological_Process_2017b,positive regulation of cell proliferation in bone marrow (GO:0071864),2/327,0.0343153267032211,0.0867083974562781,0,0,7.560384615384615,25.494850641420424,HDAC4;NRG1
331,GO_Biological_Process_2017b,histone deacetylation (GO:0016575),1/34,0.030174267482518,0.0867083974562781,0,0,35.559714795008915,124.48623298308226,HDAC4
332,GO_Biological_Process_2017b,bone morphogenesis (GO:0060349),1/34,0.030174267482518,0.0867083974562781,0,0,35.559714795008915,124.48623298308226,ANKRD11
333,GO_Biological_Process_2017b,positive regulation of dendritic spine morphogenesis (GO:0061003),1/35,0.0310485941558708,0.0867083974562781,0,0,34.5121107266436,119.83301120641356,PTPRD
347,GO_Biological_Process_2017b,positive regulation of germ cell proliferation (GO:1905938),2/327,0.0343153267032211,0.0867083974562781,0,0,7.560384615384615,25.494850641420424,HDAC4;NRG1
334,GO_Biological_Process_2017b,epiboly involved in wound healing (GO:0090505),1/36,0.0319221763964905,0.0867083974562781,0,0,33.52436974789916,115.4731604004656,NRG1
336,GO_Biological_Process_2017b,wound healing involved in inflammatory response (GO:0002246),1/37,0.0327950148043916,0.0867083974562781,0,0,32.591503267973856,111.38077026649428,NRG1
337,GO_Biological_Process_2017b,angiogenesis involved in wound healing (GO:0060055),1/38,0.0336671099659209,0.0867083974562781,0,0,31.70906200317965,107.5328454820737,NRG1
342,GO_Biological_Process_2017b,positive regulation of synoviocyte proliferation (GO:1901647),2/327,0.0343153267032211,0.0867083974562781,0,0,7.560384615384615,25.494850641420424,HDAC4;NRG1
343,GO_Biological_Process_2017b,positive regulation of mammary stem cell proliferation (GO:2000103),2/327,0.0343153267032211,0.0867083974562781,0,0,7.560384615384615,25.494850641420424,HDAC4;NRG1
340,GO_Biological_Process_2017b,positive regulation of sebum secreting cell proliferation (GO:1904004),2/327,0.0343153267032211,0.0867083974562781,0,0,7.560384615384615,25.494850641420424,HDAC4;NRG1
345,GO_Biological_Process_2017b,positive regulation of cell proliferation involved in compound eye morphogenesis (GO:2000497),2/327,0.0343153267032211,0.0867083974562781,0,0,7.560384615384615,25.494850641420424,HDAC4;NRG1
335,GO_Biological_Process_2017b,wound healing (GO:0042060),1/36,0.0319221763964905,0.0867083974562781,0,0,33.52436974789916,115.4731604004656,NRG1
338,GO_Biological_Process_2017b,odontogenesis of dentin-containing tooth (GO:0042475),1/38,0.0336671099659209,0.0867083974562781,0,0,31.70906200317965,107.5328454820737,ANKRD11
339,GO_Biological_Process_2017b,positive regulation of skeletal muscle cell proliferation (GO:0014858),2/327,0.0343153267032211,0.0867083974562781,0,0,7.560384615384615,25.494850641420424,HDAC4;NRG1
75,GO_Biological_Process_2018,B cell differentiation (GO:0030183),1/52,0.0457987338494677,0.0868391576886011,0,0,22.988465974625143,70.88490801561363,HDAC4
76,GO_Biological_Process_2018,positive regulation of nervous system development (GO:0051962),1/52,0.0457987338494677,0.0868391576886011,0,0,22.988465974625143,70.88490801561363,PTPRD
365,GO_Biological_Process_2017b,positive regulation of growth plate cartilage chondrocyte proliferation (GO:0061913),2/337,0.0362576212950633,0.0871767943706442,0,0,7.330970149253731,24.317602701157305,HDAC4;NRG1
174,WikiPathways_2019_Human,Pathways Affected in Adenoid Cystic Carcinoma WP3651,1/65,0.0569348954637786,0.0894691214430806,0,0,18.30698529411765,52.46501611587855,ERBIN
173,WikiPathways_2019_Human,Endochondral Ossification WP474,1/64,0.0560826445470321,0.0894691214430806,0,0,18.598506069094302,53.58097327195968,HDAC4
367,GO_Biological_Process_2017b,B cell proliferation (GO:0042100),1/43,0.0380164579400951,0.089931405879795,0,0,27.92717086834734,91.3144790197023,HDAC4
366,GO_Biological_Process_2017b,positive regulation of fibroblast proliferation (GO:0048146),2/345,0.0378420034029755,0.089931405879795,0,0,7.157069970845481,23.43464894102357,HDAC4;NRG1
368,GO_Biological_Process_2017b,sucrose catabolic process via 3'-ketosucrose (GO:0019574),1/43,0.0380164579400951,0.089931405879795,0,0,27.92717086834734,91.3144790197023,PTPRD
369,GO_Biological_Process_2017b,positive regulation of smooth muscle cell proliferation (GO:0048661),2/347,0.0382422864171503,0.089973099332527,0,0,7.114855072463768,23.22155933411969,HDAC4;NRG1
370,GO_Biological_Process_2017b,positive regulation of epithelial cell proliferation (GO:0050679),2/348,0.0384430515329888,0.089973099332527,0,0,7.09393063583815,23.116121435030514,HDAC4;NRG1
371,GO_Biological_Process_2017b,activation of protein kinase B activity (GO:0032148),1/44,0.0388841061194349,0.0900474036450071,0,0,27.276333789329687,88.57088446864675,NRG1
372,GO_Biological_Process_2017b,dephosphorylation (GO:0016311),1/44,0.0388841061194349,0.0900474036450071,0,0,27.276333789329687,88.57088446864675,PTPRD
77,GO_Biological_Process_2018,anion transport (GO:0006820),1/56,0.0492384039303871,0.0907226987355692,0,0,21.31229946524064,64.173068346434,SLC13A3
78,GO_Biological_Process_2018,regulation of glycolytic process (GO:0006110),1/57,0.0500964899328297,0.0907226987355692,0,0,20.930672268907564,62.66233736405012,HDAC4
79,GO_Biological_Process_2018,epidermal growth factor receptor signaling pathway (GO:0007173),1/57,0.0500964899328297,0.0907226987355692,0,0,20.930672268907564,62.66233736405012,ERBIN
80,GO_Biological_Process_2018,integrin-mediated signaling pathway (GO:0007229),1/58,0.0509538444953197,0.0907226987355692,0,0,20.562435500516,61.21097903869968,ERBIN
81,GO_Biological_Process_2018,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),1/58,0.0509538444953197,0.0907226987355692,0,0,20.562435500516,61.21097903869968,PTPRD
373,GO_Biological_Process_2017b,plasma membrane repair (GO:0001778),1/45,0.0397510152021215,0.0915730193137878,0,0,26.655080213903744,85.9658295948253,NRG1
374,GO_Biological_Process_2017b,phosphorylation (GO:0016310),1/46,0.0406171857845244,0.0930810507562018,0,0,26.06143790849673,83.48948444789488,PTPRD
375,GO_Biological_Process_2017b,positive regulation of cell motility (GO:2000147),1/47,0.0414826184608072,0.0940842892925524,0,0,25.493606138107417,81.1329113370927,NRG1
376,GO_Biological_Process_2017b,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),1/47,0.0414826184608072,0.0940842892925524,0,0,25.493606138107417,81.1329113370927,PTPRD
377,GO_Biological_Process_2017b,response to interleukin-1 (GO:0070555),1/48,0.0423473138141528,0.0955529132216782,0,0,24.94993742177722,78.88796682594588,HDAC4
378,GO_Biological_Process_2017b,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),1/49,0.0432112724444188,0.0960250498764864,0,0,24.42892156862745,76.74721626832032,NRG1
379,GO_Biological_Process_2017b,mature B cell differentiation (GO:0002335),1/49,0.0432112724444188,0.0960250498764864,0,0,24.42892156862745,76.74721626832032,HDAC4
380,GO_Biological_Process_2017b,B cell lineage commitment (GO:0002326),1/49,0.0432112724444188,0.0960250498764864,0,0,24.42892156862745,76.74721626832032,HDAC4
82,GO_Biological_Process_2018,positive regulation of cell proliferation (GO:0008284),2/424,0.054856045732115,0.0964937671914312,0,0,5.793838862559242,16.819762630732004,HDAC4;NRG1
386,GO_Biological_Process_2017b,epidermal growth factor receptor signaling pathway via positive regulation of NF-kappaB transcription factor activity (GO:0038167),1/52,0.0457987338494677,0.0968819369892586,0,0,22.988465974625143,70.88490801561363,ERBIN
381,GO_Biological_Process_2017b,negative regulation of protein homodimerization activity (GO:0090074),1/50,0.0440744949316926,0.0968819369892586,0,0,23.92917166866747,74.70385911458476,NRG1
382,GO_Biological_Process_2017b,immature B cell differentiation (GO:0002327),1/51,0.0449369818711912,0.0968819369892586,0,0,23.44941176470588,72.75166337328601,HDAC4
383,GO_Biological_Process_2017b,positive regulation of protein homodimerization activity (GO:0090073),1/51,0.0449369818711912,0.0968819369892586,0,0,23.44941176470588,72.75166337328601,NRG1
390,GO_Biological_Process_2017b,gurken signaling pathway (GO:0008314),1/52,0.0457987338494677,0.0968819369892586,0,0,22.988465974625143,70.88490801561363,ERBIN
389,GO_Biological_Process_2017b,epidermal growth factor receptor signaling pathway involved in heart process (GO:1905251),1/52,0.0457987338494677,0.0968819369892586,0,0,22.988465974625143,70.88490801561363,ERBIN
384,GO_Biological_Process_2017b,epidermal growth factor signaling pathway involved in forebrain neuron fate commitment (GO:0022026),1/52,0.0457987338494677,0.0968819369892586,0,0,22.988465974625143,70.88490801561363,ERBIN
387,GO_Biological_Process_2017b,epidermal growth factor receptor signaling pathway involved in lung development (GO:0060507),1/52,0.0457987338494677,0.0968819369892586,0,0,22.988465974625143,70.88490801561363,ERBIN
385,GO_Biological_Process_2017b,epidermal growth factor receptor signaling pathway via MAPK cascade (GO:0038029),1/52,0.0457987338494677,0.0968819369892586,0,0,22.988465974625143,70.88490801561363,ERBIN
388,GO_Biological_Process_2017b,ERBB4-EGFR signaling pathway (GO:0038137),1/52,0.0457987338494677,0.0968819369892586,0,0,22.988465974625143,70.88490801561363,ERBIN
83,GO_Biological_Process_2018,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),1/65,0.0569348954637786,0.0989582706870437,0,0,18.30698529411765,52.46501611587855,HDAC4
393,GO_Biological_Process_2017b,integrin-mediated signaling pathway (GO:0007229),1/54,0.0475200352874264,0.0990939124477139,0,0,22.11875693673696,67.38709029166962,ERBIN
391,GO_Biological_Process_2017b,negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433),1/54,0.0475200352874264,0.0990939124477139,0,0,22.11875693673696,67.38709029166962,HDAC4
392,GO_Biological_Process_2017b,negative regulation of protein binding (GO:0032091),1/54,0.0475200352874264,0.0990939124477139,0,0,22.11875693673696,67.38709029166962,HDAC4
394,GO_Biological_Process_2017b,positive regulation of protein binding (GO:0032092),1/55,0.0483795859097418,0.1000043340488192,0,0,21.70806100217865,65.7467122997584,HDAC4
425,GO_Biological_Process_2017b,neuron differentiation involved in amphid sensory organ development (GO:0003387),1/63,0.0552296663042342,0.1000043340488192,0,0,18.89943074003795,54.73757147758474,PTPRD
424,GO_Biological_Process_2017b,glutamatergic neuron differentiation (GO:1905962),1/63,0.0552296663042342,0.1000043340488192,0,0,18.89943074003795,54.73757147758474,PTPRD
423,GO_Biological_Process_2017b,medial motor column neuron differentiation (GO:0021526),1/63,0.0552296663042342,0.1000043340488192,0,0,18.89943074003795,54.73757147758474,PTPRD
422,GO_Biological_Process_2017b,mechanoreceptor differentiation (GO:0042490),1/63,0.0552296663042342,0.1000043340488192,0,0,18.89943074003795,54.73757147758474,PTPRD
421,GO_Biological_Process_2017b,Rohon-Beard neuron differentiation (GO:1905275),1/63,0.0552296663042342,0.1000043340488192,0,0,18.89943074003795,54.73757147758474,PTPRD
420,GO_Biological_Process_2017b,neuron differentiation involved in salivary gland development (GO:0060705),1/63,0.0552296663042342,0.1000043340488192,0,0,18.89943074003795,54.73757147758474,PTPRD
419,GO_Biological_Process_2017b,retinal bipolar neuron differentiation (GO:0060040),1/63,0.0552296663042342,0.1000043340488192,0,0,18.89943074003795,54.73757147758474,PTPRD
418,GO_Biological_Process_2017b,photoreceptor cell differentiation (GO:0046530),1/63,0.0552296663042342,0.1000043340488192,0,0,18.89943074003795,54.73757147758474,PTPRD
417,GO_Biological_Process_2017b,"negative regulation of DNA-templated transcription, initiation (GO:2000143)",2/424,0.054856045732115,0.1000043340488192,0,0,5.793838862559242,16.819762630732004,HDAC4;NRG1
416,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase III promoter (GO:0016480),2/423,0.0546260263910496,0.1000043340488192,0,0,5.807897862232779,16.884981067848866,HDAC4;NRG1
415,GO_Biological_Process_2017b,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",2/422,0.0543963631343197,0.1000043340488192,0,0,5.8220238095238095,16.950577688742165,HDAC4;NRG1
414,GO_Biological_Process_2017b,positive regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation (GO:2000081),2/419,0.0537095173259708,0.1000043340488192,0,0,5.8648081534772185,17.149667096410305,HDAC4;NRG1
395,GO_Biological_Process_2017b,inositol phosphate metabolic process (GO:0043647),1/57,0.0500964899328297,0.1000043340488192,0,0,20.930672268907564,62.66233736405012,PTPRD
413,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase I promoter (GO:0016479),2/419,0.0537095173259708,0.1000043340488192,0,0,5.8648081534772185,17.149667096410305,HDAC4;NRG1
410,GO_Biological_Process_2017b,"negative regulation of DNA-templated transcription, termination (GO:0060567)",2/414,0.052571965767079,0.1000043340488192,0,0,5.9375,17.48933536218089,HDAC4;NRG1
409,GO_Biological_Process_2017b,carbon catabolite repression of transcription (GO:0045013),2/413,0.0523455409346631,0.1000043340488192,0,0,5.952250608272506,17.558475756772538,HDAC4;NRG1
408,GO_Biological_Process_2017b,negative regulation of transcription by transcription factor catabolism (GO:0010620),2/413,0.0523455409346631,0.1000043340488192,0,0,5.952250608272506,17.558475756772538,HDAC4;NRG1
407,GO_Biological_Process_2017b,negative regulation of transcription involved in G2/M transition of mitotic cell cycle (GO:0090419),2/413,0.0523455409346631,0.1000043340488192,0,0,5.952250608272506,17.558475756772538,HDAC4;NRG1
406,GO_Biological_Process_2017b,chromatin organization involved in negative regulation of transcription (GO:0097549),2/412,0.0521194796819718,0.1000043340488192,0,0,5.967073170731707,17.628026076478744,HDAC4;NRG1
405,GO_Biological_Process_2017b,negative regulation of transcription during mitotic cell cycle (GO:0007068),2/412,0.0521194796819718,0.1000043340488192,0,0,5.967073170731707,17.628026076478744,HDAC4;NRG1
404,GO_Biological_Process_2017b,"negative regulation of mating-type specific transcription, DNA-templated (GO:0045894)",2/412,0.0521194796819718,0.1000043340488192,0,0,5.967073170731707,17.628026076478744,HDAC4;NRG1
403,GO_Biological_Process_2017b,negative regulation of ncRNA transcription associated with protein coding gene TSS/TES (GO:1904388),2/412,0.0521194796819718,0.1000043340488192,0,0,5.967073170731707,17.628026076478744,HDAC4;NRG1
402,GO_Biological_Process_2017b,negative regulation of transcription by pheromones (GO:0045996),2/412,0.0521194796819718,0.1000043340488192,0,0,5.967073170731707,17.628026076478744,HDAC4;NRG1
401,GO_Biological_Process_2017b,"negative regulation of cellular carbohydrate metabolic process by negative regulation of transcription, DNA-templated (GO:0010678)",2/412,0.0521194796819718,0.1000043340488192,0,0,5.967073170731707,17.628026076478744,HDAC4;NRG1
400,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase V promoter (GO:1904280),2/412,0.0521194796819718,0.1000043340488192,0,0,5.967073170731707,17.628026076478744,HDAC4;NRG1
399,GO_Biological_Process_2017b,negative regulation of antisense RNA transcription (GO:0060195),2/412,0.0521194796819718,0.1000043340488192,0,0,5.967073170731707,17.628026076478744,HDAC4;NRG1
398,GO_Biological_Process_2017b,nitrogen catabolite repression of transcription (GO:0090295),2/412,0.0521194796819718,0.1000043340488192,0,0,5.967073170731707,17.628026076478744,HDAC4;NRG1
397,GO_Biological_Process_2017b,phospholipid metabolic process (GO:0006644),1/59,0.051810468206973,0.1000043340488192,0,0,20.20689655172414,59.81570875382696,PTPRD
412,GO_Biological_Process_2017b,B cell differentiation (GO:0030183),1/61,0.0535215254426699,0.1000043340488192,0,0,19.531372549019608,57.18144005818292,HDAC4
396,GO_Biological_Process_2017b,negative regulation of CREB transcription factor activity (GO:0032792),1/57,0.0500964899328297,0.1000043340488192,0,0,20.930672268907564,62.66233736405012,HDAC4
411,GO_Biological_Process_2017b,negative regulation of transcription by competitive promoter binding (GO:0010944),2/416,0.0530259031730843,0.1000043340488192,0,0,5.908212560386473,17.35227108213742,HDAC4;NRG1
428,GO_Biological_Process_2017b,negative regulation of transcription by transcription factor localization (GO:0010621),2/432,0.0567089301669923,0.1008969231360872,0,0,5.683720930232558,16.311276359736333,HDAC4;NRG1
427,GO_Biological_Process_2017b,negative regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0071930),2/430,0.0562435978199366,0.1008969231360872,0,0,5.7108644859813085,16.436228122963634,HDAC4;NRG1
429,GO_Biological_Process_2017b,chromatin remodeling (GO:0006338),1/66,0.0577864196143044,0.1008969231360872,0,0,18.02443438914027,51.38768922197736,HDAC4
426,GO_Biological_Process_2017b,GABAergic neuron differentiation (GO:0097154),1/64,0.0560826445470321,0.1008969231360872,0,0,18.598506069094302,53.58097327195968,PTPRD
433,GO_Biological_Process_2017b,cardiac neuron differentiation (GO:0060945),1/66,0.0577864196143044,0.1008969231360872,0,0,18.02443438914027,51.38768922197736,PTPRD
432,GO_Biological_Process_2017b,negative regulation of androgen receptor activity (GO:2000824),1/66,0.0577864196143044,0.1008969231360872,0,0,18.02443438914027,51.38768922197736,HDAC4
431,GO_Biological_Process_2017b,regulation of cell migration (GO:0030334),1/66,0.0577864196143044,0.1008969231360872,0,0,18.02443438914027,51.38768922197736,NRG1
430,GO_Biological_Process_2017b,chromatin remodeling in response to cation stress (GO:0043156),1/66,0.0577864196143044,0.1008969231360872,0,0,18.02443438914027,51.38768922197736,HDAC4
434,GO_Biological_Process_2017b,chromatin remodeling at centromere (GO:0031055),1/66,0.0577864196143044,0.1008969231360872,0,0,18.02443438914027,51.38768922197736,HDAC4
435,GO_Biological_Process_2017b,nucleosome mobilization (GO:0042766),1/67,0.0586372175990698,0.1015762824550815,0,0,17.750445632798574,50.34710965358108,HDAC4
436,GO_Biological_Process_2017b,noradrenergic neuron differentiation (GO:0003357),1/67,0.0586372175990698,0.1015762824550815,0,0,17.750445632798574,50.34710965358108,PTPRD
438,GO_Biological_Process_2017b,neuron fate commitment (GO:0048663),1/68,0.0594872899827324,0.1018459439393085,0,0,17.484635645302898,49.34151245692923,PTPRD
437,GO_Biological_Process_2017b,positive regulation of cell proliferation (GO:0008284),2/442,0.0590564388936806,0.1018459439393085,0,0,5.5517045454545455,15.707225045167542,HDAC4;NRG1
439,GO_Biological_Process_2017b,amacrine cell differentiation (GO:0035881),1/68,0.0594872899827324,0.1018459439393085,0,0,17.484635645302898,49.34151245692923,PTPRD
84,GO_Biological_Process_2018,negative regulation of nucleic acid-templated transcription (GO:1903507),2/444,0.0595300690031704,0.1022516479348575,0,0,5.526018099547511,15.590409710594148,HDAC4;NRG1
440,GO_Biological_Process_2017b,negative regulation of thyroid hormone receptor activity (GO:1904168),1/69,0.0603366373648496,0.1028996916299761,0,0,17.226643598615915,48.3692416453001,HDAC4
441,GO_Biological_Process_2017b,neuron differentiation (GO:0030182),1/70,0.0611852603166933,0.1039440715804829,0,0,16.97612958226769,47.42874202866335,PTPRD
442,GO_Biological_Process_2017b,positive regulation of epithelial cell proliferation involved in wound healing (GO:0060054),1/72,0.0628803352568931,0.1060051628851837,0,0,16.496271748135875,45.63729539644487,NRG1
443,GO_Biological_Process_2017b,hair cell differentiation (GO:0035315),1/72,0.0628803352568931,0.1060051628851837,0,0,16.496271748135875,45.63729539644487,PTPRD
86,GO_Biological_Process_2018,B cell activation (GO:0042113),1/73,0.063726788409155,0.1061217692288897,0,0,16.266339869281047,44.783677915691136,HDAC4
85,GO_Biological_Process_2018,lymphocyte differentiation (GO:0030098),1/73,0.063726788409155,0.1061217692288897,0,0,16.266339869281047,44.783677915691136,HDAC4
87,GO_Biological_Process_2018,"regulation of gene expression, epigenetic (GO:0040029)",1/74,0.0645725194547735,0.1061217692288897,0,0,16.042707493956488,43.95647876269956,HDAC4
88,GO_Biological_Process_2018,negative regulation of phosphorylation (GO:0042326),1/75,0.0654175289767128,0.1061217692288897,0,0,15.825119236883944,43.154546742931096,HDAC4
89,GO_Biological_Process_2018,gland development (GO:0048732),1/75,0.0654175289767128,0.1061217692288897,0,0,15.825119236883944,43.154546742931096,NRG1
90,GO_Biological_Process_2018,response to interleukin-1 (GO:0070555),1/76,0.0662618175517913,0.1063101688193575,0,0,15.613333333333332,42.376795202067306,HDAC4
444,GO_Biological_Process_2017b,ATP-dependent chromatin remodeling (GO:0043044),1/75,0.0654175289767128,0.1098614990448613,0,0,15.825119236883944,43.154546742931096,HDAC4
445,GO_Biological_Process_2017b,ERBB signaling pathway (GO:0038127),1/76,0.0662618175517913,0.1104363625863189,0,0,15.613333333333332,42.376795202067306,NRG1
446,GO_Biological_Process_2017b,phagolysosome assembly (GO:0001845),1/76,0.0662618175517913,0.1104363625863189,0,0,15.613333333333332,42.376795202067306,ADORA1
447,GO_Biological_Process_2017b,peripheral nervous system neuron differentiation (GO:0048934),1/77,0.0671053857579431,0.111420263145264,0,0,15.407120743034056,41.62219761611141,PTPRD
91,GO_Biological_Process_2018,positive regulation of protein targeting to mitochondrion (GO:1903955),1/81,0.070472466450265,0.1118367402362901,0,0,14.633823529411766,38.81670264132201,NRG1
92,GO_Biological_Process_2018,negative regulation of NF-kappaB transcription factor activity (GO:0032088),1/82,0.0713124414727928,0.1119528651078252,0,0,14.452432824981845,38.16431494463284,ERBIN
449,GO_Biological_Process_2017b,dopaminergic neuron differentiation (GO:0071542),1/78,0.0679482341709108,0.1119746181093661,0,0,15.206264323911382,40.88978353793229,PTPRD
448,GO_Biological_Process_2017b,heterochromatin assembly (GO:0031507),1/78,0.0679482341709108,0.1119746181093661,0,0,15.206264323911382,40.88978353793229,HDAC4
450,GO_Biological_Process_2017b,detection of lipopolysaccharide (GO:0032497),1/80,0.0696317739420862,0.1143208228899922,0,0,14.819806403574088,39.48788238772356,ERBIN
175,WikiPathways_2019_Human,ErbB Signaling Pathway WP673,1/91,0.0788400249120094,0.1156320365376138,0,0,13.001307189542484,33.02766894797317,NRG1
95,GO_Biological_Process_2018,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),2/512,0.0764069423293717,0.1162022247925861,0,0,4.772549019607843,12.27347706557533,HDAC4;NRG1
94,GO_Biological_Process_2018,regulation of protein targeting to mitochondrion (GO:1903214),1/88,0.0763372567298681,0.1162022247925861,0,0,13.451656524678835,34.60565311468726,NRG1
93,GO_Biological_Process_2018,positive regulation of cellular component biogenesis (GO:0044089),1/87,0.075501574519904,0.1162022247925861,0,0,13.60875512995896,35.15960381916263,PTPRD
451,GO_Biological_Process_2017b,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),1/82,0.0713124414727928,0.1166448856804045,0,0,14.452432824981845,38.16431494463284,NRG1
457,GO_Biological_Process_2017b,activation of MAPK activity involved in conjugation with cellular fusion (GO:0071508),1/84,0.0729902413804037,0.1167843862086459,0,0,14.10276399716513,36.91299089130259,NRG1
455,GO_Biological_Process_2017b,activation of MAPK activity involved in osmosensory signaling pathway (GO:0000169),1/84,0.0729902413804037,0.1167843862086459,0,0,14.10276399716513,36.91299089130259,NRG1
456,GO_Biological_Process_2017b,activation of MAPK activity involved in cell wall organization or biogenesis (GO:0000199),1/84,0.0729902413804037,0.1167843862086459,0,0,14.10276399716513,36.91299089130259,NRG1
452,GO_Biological_Process_2017b,peptidyl-N-phospho-arginine dephosphorylation (GO:0098628),1/83,0.0721516995917754,0.1167843862086459,0,0,14.275466284074604,37.52997870137401,PTPRD
453,GO_Biological_Process_2017b,peptidyl-histidine dephosphorylation (GO:0035971),1/83,0.0721516995917754,0.1167843862086459,0,0,14.275466284074604,37.52997870137401,PTPRD
454,GO_Biological_Process_2017b,regulation of translational initiation by eIF2 alpha dephosphorylation (GO:0036496),1/84,0.0729902413804037,0.1167843862086459,0,0,14.10276399716513,36.91299089130259,PTPRD
96,GO_Biological_Process_2018,positive regulation of cellular process (GO:0048522),2/519,0.0782248897444228,0.1177405556977911,0,0,4.706237911025145,11.992282016320116,HDAC4;NRG1
460,GO_Biological_Process_2017b,"regulation of gene expression, epigenetic (GO:0040029)",1/86,0.0746651782709374,0.1181751022993254,0,0,13.76955017301038,35.728422579909434,HDAC4
459,GO_Biological_Process_2017b,activation of MAPK activity involved in innate immune response (GO:0035419),1/86,0.0746651782709374,0.1181751022993254,0,0,13.76955017301038,35.728422579909434,NRG1
458,GO_Biological_Process_2017b,neuron development (GO:0048666),1/86,0.0746651782709374,0.1181751022993254,0,0,13.76955017301038,35.728422579909434,PTPRD
461,GO_Biological_Process_2017b,peptidyl-serine dephosphorylation (GO:0070262),1/88,0.0763372567298681,0.1195626028673673,0,0,13.451656524678835,34.60565311468726,PTPRD
462,GO_Biological_Process_2017b,positive regulation of protein import into mitochondrial outer membrane (GO:1903638),1/89,0.0771722254871189,0.1195626028673673,0,0,13.29812834224599,34.06602362525984,NRG1
463,GO_Biological_Process_2017b,response to lipopolysaccharide (GO:0032496),1/89,0.0771722254871189,0.1195626028673673,0,0,13.29812834224599,34.06602362525984,ERBIN
464,GO_Biological_Process_2017b,phagocytosis (GO:0006909),1/89,0.0771722254871189,0.1195626028673673,0,0,13.29812834224599,34.06602362525984,ADORA1
465,GO_Biological_Process_2017b,peptidyl-threonine dephosphorylation (GO:0035970),1/89,0.0771722254871189,0.1195626028673673,0,0,13.29812834224599,34.06602362525984,PTPRD
466,GO_Biological_Process_2017b,positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091),1/89,0.0771722254871189,0.1195626028673673,0,0,13.29812834224599,34.06602362525984,HDAC4
468,GO_Biological_Process_2017b,activation of MAPK activity by adrenergic receptor signaling pathway (GO:0071883),1/90,0.0780064813617029,0.1195918181155028,0,0,13.148050231328488,33.54019441349092,NRG1
467,GO_Biological_Process_2017b,"phagocytosis, engulfment (GO:0006911)",1/90,0.0780064813617029,0.1195918181155028,0,0,13.148050231328488,33.54019441349092,ADORA1
469,GO_Biological_Process_2017b,cellular response to interleukin-1 (GO:0071347),1/90,0.0780064813617029,0.1195918181155028,0,0,13.148050231328488,33.54019441349092,HDAC4
176,WikiPathways_2019_Human,Neural Crest Differentiation WP2064,1/101,0.0871364089944587,0.1198125623673807,0,0,11.69529411764706,28.539797811620943,HDAC4
470,GO_Biological_Process_2017b,negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),1/91,0.0788400249120094,0.1204500380600144,0,0,13.001307189542484,33.02766894797317,NRG1
471,GO_Biological_Process_2017b,histone dephosphorylation (GO:0016576),1/92,0.0796728567374856,0.1208829550499782,0,0,12.857789269553976,32.527973699604026,PTPRD
472,GO_Biological_Process_2017b,positive regulation of hh target transcription factor activity (GO:0007228),1/92,0.0796728567374856,0.1208829550499782,0,0,12.857789269553976,32.527973699604026,HDAC4
97,GO_Biological_Process_2018,response to tumor necrosis factor (GO:0034612),1/97,0.083826359716664,0.1235962023168445,0,0,12.185049019607844,30.20683114705019,ERBIN
99,GO_Biological_Process_2018,histone modification (GO:0016570),1/98,0.0846549330937291,0.1235962023168445,0,0,12.058823529411764,29.775308154544383,HDAC4
98,GO_Biological_Process_2018,response to molecule of bacterial origin (GO:0002237),1/98,0.0846549330937291,0.1235962023168445,0,0,12.058823529411764,29.775308154544383,ERBIN
473,GO_Biological_Process_2017b,positive regulation of androgen receptor activity (GO:2000825),1/95,0.0821670874636413,0.1242388951340281,0,0,12.445556946182728,31.101452445343085,HDAC4
474,GO_Biological_Process_2017b,peptidyl-tyrosine dephosphorylation (GO:0035335),1/97,0.083826359716664,0.1263136927237403,0,0,12.185049019607844,30.20683114705019,PTPRD
475,GO_Biological_Process_2017b,positive regulation of thyroid hormone receptor activity (GO:1904169),1/99,0.0854827987095899,0.1279334402456448,0,0,11.935174069627852,29.35384580236193,HDAC4
476,GO_Biological_Process_2017b,phosphatidylinositol-mediated signaling (GO:0048015),1/99,0.0854827987095899,0.1279334402456448,0,0,11.935174069627852,29.35384580236193,NRG1
100,GO_Biological_Process_2018,positive regulation of cellular component organization (GO:0051130),1/106,0.0912580888842393,0.1319176334366231,0,0,11.135574229691876,26.659273431080635,PTPRD
477,GO_Biological_Process_2017b,positive regulation of CREB transcription factor activity (GO:0032793),1/103,0.0887871950954723,0.1324283587864672,0,0,11.46482122260669,27.76221178459644,HDAC4
102,GO_Biological_Process_2018,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),1/110,0.0945427716606664,0.1340120841015271,0,0,10.724770642201834,25.296548009342803,NRG1
101,GO_Biological_Process_2018,regulation of cell motility (GO:2000145),1/109,0.0937226537969026,0.1340120841015271,0,0,10.824618736383442,25.6263685491649,NRG1
105,GO_Biological_Process_2018,activation of MAPK activity (GO:0000187),1/117,0.1002640016593071,0.138099473983574,0,0,10.074036511156187,23.16976571809541,NRG1
104,GO_Biological_Process_2018,chromatin remodeling (GO:0006338),1/116,0.0994487786044948,0.138099473983574,0,0,10.162148337595909,23.45538216642873,HDAC4
103,GO_Biological_Process_2018,peptidyl-lysine modification (GO:0018205),1/115,0.0986328580009636,0.138099473983574,0,0,10.251805985552116,23.74677927740439,HDAC4
177,WikiPathways_2019_Human,mRNA Processing WP411,1/126,0.107569710770567,0.1392078609972044,0,0,9.344470588235296,20.83458271705315,SREK1
478,GO_Biological_Process_2017b,cellular response to tumor necrosis factor (GO:0071356),1/109,0.0937226537969026,0.1393174583467472,0,0,10.824618736383442,25.6263685491649,ERBIN
479,GO_Biological_Process_2017b,skeletal system morphogenesis (GO:0048705),1/110,0.0945427716606664,0.1400633654232094,0,0,10.724770642201834,25.296548009342803,ANKRD11
106,GO_Biological_Process_2018,enzyme linked receptor protein signaling pathway (GO:0007167),1/120,0.1027054909715507,0.1401402026340786,0,0,9.818586258032624,22.3460193071682,PTPRD
107,GO_Biological_Process_2018,negative regulation of gene expression (GO:0010629),2/618,0.105347112991476,0.1417006194282391,0,0,3.929788961038961,8.843968612274734,HDAC4;NRG1
108,GO_Biological_Process_2018,dephosphorylation (GO:0016311),1/124,0.1059510780315295,0.1417006194282391,0,0,9.49736967957915,21.31948479946905,PTPRD
109,GO_Biological_Process_2018,protein dephosphorylation (GO:0006470),1/125,0.1067607406651116,0.1417006194282391,0,0,9.420303605313093,21.074773673487663,PTPRD
110,GO_Biological_Process_2018,positive regulation of protein kinase B signaling (GO:0051897),1/127,0.1083779888894848,0.1423311967444088,0,0,9.26984126984127,20.598794838572697,NRG1
111,GO_Biological_Process_2018,positive regulation of mitochondrion organization (GO:0010822),1/128,0.1091855755847519,0.1423311967444088,0,0,9.196387216303844,20.36729685335,NRG1
112,GO_Biological_Process_2018,generation of neurons (GO:0048699),1/130,0.1107986769436176,0.1431558126882139,0,0,9.052895576835386,19.91673641957648,PTPRD
480,GO_Biological_Process_2017b,positive regulation of protein targeting to mitochondrion (GO:1903955),1/113,0.0969989218002412,0.1432198845372689,0,0,10.4359243697479,24.3475898718272,NRG1
481,GO_Biological_Process_2017b,phosphatidylinositol 3-kinase signaling (GO:0014065),1/114,0.0978162392503257,0.1439436296660312,0,0,10.343050494534095,24.04412406695568,NRG1
113,GO_Biological_Process_2018,phagocytosis (GO:0006909),1/135,0.1148193693672815,0.1470493677861676,0,0,8.712906057945567,18.858171061974925,ADORA1
114,GO_Biological_Process_2018,response to cytokine (GO:0034097),1/138,0.1172235366155797,0.148274713991423,0,0,8.520824388149421,18.26585775015061,HDAC4
115,GO_Biological_Process_2018,neuron differentiation (GO:0030182),1/139,0.1180235543171916,0.148274713991423,0,0,8.458653026427962,18.075050872110797,PTPRD
116,GO_Biological_Process_2018,response to lipid (GO:0033993),1/140,0.118822887239702,0.148274713991423,0,0,8.39737621667372,17.887429414854076,ERBIN
117,GO_Biological_Process_2018,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),1/142,0.1204195010018536,0.1489936198836494,0,0,8.277430120984564,17.521447135021635,PTPRD
118,GO_Biological_Process_2018,cellular protein complex assembly (GO:0043623),1/144,0.1220133823045622,0.149697090894673,0,0,8.160839160839162,17.167341601168975,NRG1
119,GO_Biological_Process_2018,skeletal system development (GO:0001501),1/146,0.1236045355363844,0.1503855182359344,0,0,8.047464503042596,16.82457683434384,ANKRD11
178,WikiPathways_2019_Human,NRF2 pathway WP2884,1/146,0.1236045355363844,0.1510722101000254,0,0,8.047464503042596,16.82457683434384,NRG1
120,GO_Biological_Process_2018,positive regulation of intracellular protein transport (GO:0090316),1/152,0.1283616707475379,0.154882677100335,0,0,7.725360342812622,15.859418874897433,NRG1
121,GO_Biological_Process_2018,response to lipopolysaccharide (GO:0032496),1/155,0.1307310829477655,0.1564486730358505,0,0,7.573720397249809,15.409588975790411,ERBIN
482,GO_Biological_Process_2017b,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),1/126,0.107569710770567,0.1577689091301649,0,0,9.344470588235296,20.83458271705315,NRG1
122,GO_Biological_Process_2018,regulation of protein kinase B signaling (GO:0051896),1/163,0.1370198116411668,0.1626414024358565,0,0,7.19680464778504,14.304583045111348,NRG1
483,GO_Biological_Process_2017b,cellular response to lipopolysaccharide (GO:0071222),1/132,0.1124090192777675,0.1643188321668363,0,0,8.913785361472833,19.48206824738867,ERBIN
484,GO_Biological_Process_2017b,"negative regulation of gene expression, epigenetic (GO:0045814)",1/133,0.1132131572099071,0.1649463217627786,0,0,8.845811051693405,19.27044802603592,HDAC4
123,GO_Biological_Process_2018,regulation of cell proliferation (GO:0042127),2/740,0.1417826034567077,0.1669375814893494,0,0,3.2594850948509486,6.367274914000578,HDAC4;NRG1
485,GO_Biological_Process_2017b,activation of MAPK activity (GO:0000187),1/137,0.1164228335754234,0.1690628606375785,0,0,8.583910034602075,18.459926845841217,NRG1
124,GO_Biological_Process_2018,positive regulation of MAP kinase activity (GO:0043406),1/177,0.1479218196071764,0.1727726853011821,0,0,6.619652406417113,12.650628330192763,NRG1
486,GO_Biological_Process_2017b,activation of JUN kinase activity (GO:0007257),1/143,0.1212167829384625,0.1754453437267221,0,0,8.218724109362055,17.34294402575858,NRG1
125,GO_Biological_Process_2018,phosphate-containing compound metabolic process (GO:0006796),1/183,0.1525541767130676,0.1767691253976815,0,0,6.399482870071106,12.03253480284285,PTPRD
126,GO_Biological_Process_2018,cellular response to tumor necrosis factor (GO:0071356),1/194,0.1609851212681268,0.1850695094893427,0,0,6.03139286802804,11.01599729101681,ERBIN
127,GO_Biological_Process_2018,"negative regulation of transcription, DNA-templated (GO:0045892)",2/813,0.1647955008025017,0.1879698681028535,0,0,2.9548397040690504,5.327723618605488,HDAC4;NRG1
179,WikiPathways_2019_Human,Circadian rhythm related genes WP3594,1/201,0.1663089555580513,0.1925682643303752,0,0,5.818235294117647,10.437379086756568,ADORA1
487,GO_Biological_Process_2017b,central nervous system neuron differentiation (GO:0021953),1/159,0.1338808378259637,0.1931395693227018,0,0,7.380491437081162,14.840730151520052,PTPRD
128,GO_Biological_Process_2018,positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091),1/215,0.1768610562307949,0.2001683272069462,0,0,5.4337548103353495,9.413387102196012,HDAC4
129,GO_Biological_Process_2018,ion transmembrane transport (GO:0034220),1/219,0.1798526949909336,0.2019884112975101,0,0,5.332973556395035,9.149340756756814,SLC13A3
180,WikiPathways_2019_Human,VEGFA-VEGFR2 Signaling Pathway WP3888,1/236,0.1924529753510152,0.2116982728861167,0,0,4.942928660826032,8.145469138844097,HDAC4
130,GO_Biological_Process_2018,activation of protein kinase activity (GO:0032147),1/233,0.1902427648031118,0.212026287490491,0,0,5.007606490872211,8.309894188622586,NRG1
488,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in neuron differentiation (GO:1904081),2/770,0.1511465008527077,0.2173348378274228,0,0,3.127278645833333,5.909010852398597,HDAC4;PTPRD
181,WikiPathways_2019_Human,"GPCRs, Class A Rhodopsin-like WP455",1/257,0.2077656656008137,0.217659268724662,0,0,4.532628676470588,7.122320878733295,ADORA1
155,KEGG_2019_Human,Alcoholism,1/180,0.1502409793813054,0.2182632085686994,0,0,6.507722642129478,12.335484222996,HDAC4
148,KEGG_2019_Human,ErbB signaling pathway,1/85,0.0738280674139551,0.2182632085686994,0,0,13.934173669467787,36.31268374332498,NRG1
147,KEGG_2019_Human,Renin secretion,1/69,0.0603366373648496,0.2182632085686994,0,0,17.226643598615915,48.3692416453001,ADORA1
146,KEGG_2019_Human,Regulation of lipolysis in adipocytes,1/55,0.0483795859097418,0.2182632085686994,0,0,21.70806100217865,65.7467122997584,ADORA1
151,KEGG_2019_Human,Purine metabolism,1/129,0.1099924714179828,0.2182632085686994,0,0,9.124080882352942,20.13997932609556,GDA
152,KEGG_2019_Human,Apelin signaling pathway,1/137,0.1164228335754234,0.2182632085686994,0,0,8.583910034602075,18.459926845841217,HDAC4
153,KEGG_2019_Human,cGMP-PKG signaling pathway,1/166,0.139366987817599,0.2182632085686994,0,0,7.06488413547237,13.922375947326568,ADORA1
154,KEGG_2019_Human,NOD-like receptor signaling pathway,1/178,0.1486955362376284,0.2182632085686994,0,0,6.581920903954802,12.544183208435394,ERBIN
156,KEGG_2019_Human,Viral carcinogenesis,1/201,0.1663089555580513,0.2182632085686994,0,0,5.818235294117647,10.437379086756568,HDAC4
149,KEGG_2019_Human,Morphine addiction,1/91,0.0788400249120094,0.2182632085686994,0,0,13.001307189542484,33.02766894797317,ADORA1
157,KEGG_2019_Human,cAMP signaling pathway,1/212,0.1746105668549595,0.2182632085686994,0,0,5.511848341232228,9.619261834720568,ADORA1
150,KEGG_2019_Human,Sphingolipid signaling pathway,1/119,0.1018923572787402,0.2182632085686994,0,0,9.902293120638086,22.615236719842347,ADORA1
489,GO_Biological_Process_2017b,protein dephosphorylation (GO:0006470),1/186,0.1548614260771356,0.2219512295568067,0,0,6.294753577106518,11.741129142703194,PTPRD
490,GO_Biological_Process_2017b,positive regulation of NF-kappaB transcription factor activity (GO:0051092),1/189,0.157162741797235,0.2245182025674786,0,0,6.193366708385482,11.46066058904648,HDAC4
131,GO_Biological_Process_2018,endocytosis (GO:0006897),1/263,0.2120900942230608,0.2345844981558096,0,0,4.427480916030534,6.865890005071797,ADORA1
132,GO_Biological_Process_2018,MAPK cascade (GO:0000165),1/278,0.2228038383368437,0.244581657121648,0,0,4.184540242089616,6.282934619193975,NRG1
133,GO_Biological_Process_2018,negative regulation of signal transduction (GO:0009968),1/283,0.2263444052627623,0.2466140534952485,0,0,4.1093032957864,6.105181726167229,NRG1
182,WikiPathways_2019_Human,Nuclear Receptors Meta-Pathway WP2882,1/319,0.2513904363966567,0.2513904363966567,0,0,3.637439881613023,5.022387932343224,NRG1
491,GO_Biological_Process_2017b,MAPK cascade (GO:0000165),1/232,0.1895047592338975,0.2672503014837016,0,0,5.029539088362617,8.36583928133549,NRG1
493,GO_Biological_Process_2017b,MAPK cascade involved in osmosensory signaling pathway (GO:0000161),1/232,0.1895047592338975,0.2672503014837016,0,0,5.029539088362617,8.36583928133549,NRG1
494,GO_Biological_Process_2017b,MAPK cascade involved in innate immune response (GO:0035420),1/232,0.1895047592338975,0.2672503014837016,0,0,5.029539088362617,8.36583928133549,NRG1
492,GO_Biological_Process_2017b,ERK5 cascade (GO:0070375),1/232,0.1895047592338975,0.2672503014837016,0,0,5.029539088362617,8.36583928133549,NRG1
495,GO_Biological_Process_2017b,"negative regulation of transcription, DNA-templated (GO:0045892)",2/895,0.1914461338749342,0.2691255556069363,0,0,2.6720324748040314,4.417267266398606,HDAC4;NRG1
496,GO_Biological_Process_2017b,MAPK cascade involved in axon regeneration (GO:1903616),1/237,0.193188445176418,0.2707099231771462,0,0,4.921734795613161,8.091770858187086,NRG1
158,KEGG_2019_Human,MicroRNAs in cancer,1/299,0.2375721301980589,0.274121688690068,0,0,3.885511251480458,5.584583136164629,HDAC4
497,GO_Biological_Process_2017b,ERK1 and ERK2 cascade (GO:0070371),1/245,0.1990494717477533,0.2780373573619411,0,0,4.758437801350048,7.681079261011621,NRG1
498,GO_Biological_Process_2017b,stress-activated MAPK cascade (GO:0051403),1/250,0.2026921685902864,0.282229601834576,0,0,4.661705646113867,7.440393900949895,NRG1
159,KEGG_2019_Human,Neuroactive ligand-receptor interaction,1/338,0.2642984602347566,0.2831769216800964,0,0,3.429045208587886,4.56294913313209,ADORA1
499,GO_Biological_Process_2017b,"positive regulation of gene expression, epigenetic (GO:0045815)",1/261,0.2106511011997868,0.2923863865233634,0,0,4.4619909502262445,6.94978320935797,HDAC4
500,GO_Biological_Process_2017b,tumor necrosis factor-mediated signaling pathway (GO:0033209),1/272,0.218534957795225,0.3023754133015692,0,0,4.27848925548079,6.506766195493984,ERBIN
501,GO_Biological_Process_2017b,MAPK import into nucleus (GO:0000189),1/273,0.2192479723428101,0.3024109963349105,0,0,4.262543252595155,6.468630594433781,NRG1
502,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter (GO:0000122),2/991,0.2234221654806449,0.3072054775358868,0,0,2.400530839231547,3.597656792921906,HDAC4;NRG1
134,GO_Biological_Process_2018,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),1/396,0.3024140385644269,0.3270551824474543,0,0,2.916902457185406,3.4884934470701143,NRG1
160,KEGG_2019_Human,Herpes simplex virus 1 infection,1/492,0.3614336070593208,0.3614336070593208,0,0,2.335090451659279,2.376367644376603,ZNF248
135,GO_Biological_Process_2018,cellular response to cytokine stimulus (GO:0071345),1/456,0.339876734136915,0.3648676704705117,0,0,2.5244990303813832,2.724369358731665,ERBIN
136,GO_Biological_Process_2018,positive regulation of intracellular signal transduction (GO:1902533),1/479,0.3537270465373631,0.3769645897405475,0,0,2.400196898843219,2.494355946913392,NRG1
137,GO_Biological_Process_2018,positive regulation of nucleic acid-templated transcription (GO:1903508),1/502,0.3673025829471877,0.388595486306445,0,0,2.287307737466244,2.2908971956065542,HDAC4
503,GO_Biological_Process_2017b,dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),1/387,0.2966243916293408,0.4065879511430217,0,0,2.9862846693081377,3.62919776036838,PTPRD
541,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase I promoter (GO:0045943),1/482,0.3555132407904096,0.4214022130152696,0,0,2.384859973095267,2.4664049771475995,HDAC4
542,GO_Biological_Process_2017b,negative regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901581),1/482,0.3555132407904096,0.4214022130152696,0,0,2.384859973095267,2.4664049771475995,HDAC4
543,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter during mitotic cell cycle (GO:0007070),1/482,0.3555132407904096,0.4214022130152696,0,0,2.384859973095267,2.4664049771475995,HDAC4
536,GO_Biological_Process_2017b,negative regulation of invasive growth in response to glucose limitation by negative regulation of transcription from RNA polymerase II promoter (GO:1900460),1/481,0.3549183614192739,0.4214022130152696,0,0,2.389950980392157,2.475672508431685,HDAC4
539,GO_Biological_Process_2017b,negative regulation of snRNA transcription from RNA polymerase II promoter (GO:1905381),1/481,0.3549183614192739,0.4214022130152696,0,0,2.389950980392157,2.475672508431685,HDAC4
530,GO_Biological_Process_2017b,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter (GO:0072365),1/481,0.3549183614192739,0.4214022130152696,0,0,2.389950980392157,2.475672508431685,HDAC4
531,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901227),1/481,0.3549183614192739,0.4214022130152696,0,0,2.389950980392157,2.475672508431685,HDAC4
532,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter by pheromones (GO:0046020),1/481,0.3549183614192739,0.4214022130152696,0,0,2.389950980392157,2.475672508431685,HDAC4
533,GO_Biological_Process_2017b,regulation of transport by negative regulation of transcription from RNA polymerase II promoter (GO:1900392),1/481,0.3549183614192739,0.4214022130152696,0,0,2.389950980392157,2.475672508431685,HDAC4
544,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter by histone modification (GO:1903758),1/482,0.3555132407904096,0.4214022130152696,0,0,2.384859973095267,2.4664049771475995,HDAC4
534,GO_Biological_Process_2017b,transfer RNA gene-mediated silencing (GO:0061587),1/481,0.3549183614192739,0.4214022130152696,0,0,2.389950980392157,2.475672508431685,HDAC4
535,GO_Biological_Process_2017b,negative regulation of induction of conjugation with cellular fusion by negative regulation of transcription from RNA polymerase II promoter (GO:1902625),1/481,0.3549183614192739,0.4214022130152696,0,0,2.389950980392157,2.475672508431685,HDAC4
538,GO_Biological_Process_2017b,positive regulation of transcription involved in exit from mitosis (GO:0007072),1/481,0.3549183614192739,0.4214022130152696,0,0,2.389950980392157,2.475672508431685,HDAC4
545,GO_Biological_Process_2017b,negative regulation of mitochondrial unfolded protein response by negative regulation of transcription from RNA polymerase II promoter (GO:1904490),1/483,0.3561076019979903,0.4214022130152696,0,0,2.379790090309983,2.4571864351258017,HDAC4
540,GO_Biological_Process_2017b,negative regulation of inositol biosynthetic process by negative regulation of transcription from RNA polymerase II promoter (GO:1900471),1/482,0.3555132407904096,0.4214022130152696,0,0,2.384859973095267,2.4664049771475995,HDAC4
547,GO_Biological_Process_2017b,negative regulation of ceramide biosynthetic process by negative regulation of transcription from RNA Polymerase II promoter (GO:0061427),1/484,0.3567014455371644,0.4214022130152696,0,0,2.374741200828157,2.4480165337649344,HDAC4
560,GO_Biological_Process_2017b,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",1/493,0.3620228102722089,0.4214022130152696,0,0,2.3302247728359635,2.3676203536051603,HDAC4
559,GO_Biological_Process_2017b,regulation of reactive oxygen species metabolic process by negative regulation of transcription from RNA polymerase II promoter (GO:1904489),1/492,0.3614336070593208,0.4214022130152696,0,0,2.335090451659279,2.376367644376603,HDAC4
558,GO_Biological_Process_2017b,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter (GO:1900387),1/491,0.3608438899822768,0.4214022130152696,0,0,2.3399759903961583,2.3851605802194147,HDAC4
557,GO_Biological_Process_2017b,positive regulation of transcription by transcription factor localization (GO:0061586),1/490,0.3602536585263624,0.4214022130152696,0,0,2.3448815108865637,2.3939994827533617,HDAC4
556,GO_Biological_Process_2017b,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",1/488,0.3590716510430721,0.4214022130152696,0,0,2.3547529894914843,2.411816484757892,HDAC4
555,GO_Biological_Process_2017b,negative regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902894),1/488,0.3590716510430721,0.4214022130152696,0,0,2.3547529894914843,2.411816484757892,HDAC4
546,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage (GO:0010768),1/484,0.3567014455371644,0.4214022130152696,0,0,2.374741200828157,2.4480165337649344,HDAC4
554,GO_Biological_Process_2017b,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),1/487,0.3584798741207277,0.4214022130152696,0,0,2.3597191963205035,2.420795241124082,HDAC4
529,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter in response to iron (GO:0034396),1/481,0.3549183614192739,0.4214022130152696,0,0,2.389950980392157,2.475672508431685,HDAC4
552,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),1/485,0.3572947717879314,0.4214022130152696,0,0,2.3697131745260087,2.438894928379322,HDAC4
551,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase III promoter (GO:0045945),1/485,0.3572947717879314,0.4214022130152696,0,0,2.3697131745260087,2.438894928379322,HDAC4
550,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation (GO:2000820),1/484,0.3567014455371644,0.4214022130152696,0,0,2.374741200828157,2.4480165337649344,HDAC4
549,GO_Biological_Process_2017b,negative regulation of transcription initiation from RNA polymerase II promoter (GO:0060633),1/484,0.3567014455371644,0.4214022130152696,0,0,2.374741200828157,2.4480165337649344,HDAC4
548,GO_Biological_Process_2017b,positive regulation of gluconeogenesis by negative regulation of transcription from RNA polymerase II promoter (GO:0035949),1/484,0.3567014455371644,0.4214022130152696,0,0,2.374741200828157,2.4480165337649344,HDAC4
553,GO_Biological_Process_2017b,positive regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0071931),1/487,0.3584798741207277,0.4214022130152696,0,0,2.3597191963205035,2.420795241124082,HDAC4
528,GO_Biological_Process_2017b,negative regulation of oligopeptide transport by negative regulation of transcription from RNA polymerase II promoter (GO:0035952),1/481,0.3549183614192739,0.4214022130152696,0,0,2.389950980392157,2.475672508431685,HDAC4
537,GO_Biological_Process_2017b,negative regulation of mating type switching by negative regulation of transcription from RNA polymerase II promoter (GO:1900474),1/481,0.3549183614192739,0.4214022130152696,0,0,2.389950980392157,2.475672508431685,HDAC4
526,GO_Biological_Process_2017b,carbon catabolite repression of transcription from RNA polymerase II promoter (GO:0000437),1/481,0.3549183614192739,0.4214022130152696,0,0,2.389950980392157,2.475672508431685,HDAC4
504,GO_Biological_Process_2017b,positive regulation of transcription from a mobile element promoter (GO:0061435),1/469,0.3477392393378797,0.4214022130152696,0,0,2.4527400703871294,2.5908352041132687,HDAC4
505,GO_Biological_Process_2017b,positive regulation of transcription by pheromones (GO:0009371),1/469,0.3477392393378797,0.4214022130152696,0,0,2.4527400703871294,2.5908352041132687,HDAC4
506,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase V promoter (GO:1904281),1/469,0.3477392393378797,0.4214022130152696,0,0,2.4527400703871294,2.5908352041132687,HDAC4
508,GO_Biological_Process_2017b,"positive regulation of mating-type specific transcription, DNA-templated (GO:0045895)",1/469,0.3477392393378797,0.4214022130152696,0,0,2.4527400703871294,2.5908352041132687,HDAC4
509,GO_Biological_Process_2017b,positive regulation of antisense RNA transcription (GO:0060196),1/469,0.3477392393378797,0.4214022130152696,0,0,2.4527400703871294,2.5908352041132687,HDAC4
510,GO_Biological_Process_2017b,positive regulation of transcription during mitotic cell cycle (GO:0045897),1/469,0.3477392393378797,0.4214022130152696,0,0,2.4527400703871294,2.5908352041132687,HDAC4
511,GO_Biological_Process_2017b,nitrogen catabolite activation of transcription (GO:0090294),1/469,0.3477392393378797,0.4214022130152696,0,0,2.4527400703871294,2.5908352041132687,HDAC4
512,GO_Biological_Process_2017b,positive regulation of transcription from mitochondrial promoter (GO:1903109),1/469,0.3477392393378797,0.4214022130152696,0,0,2.4527400703871294,2.5908352041132687,HDAC4
513,GO_Biological_Process_2017b,carbon catabolite activation of transcription (GO:0045991),1/470,0.3483403695843184,0.4214022130152696,0,0,2.4473849241189014,2.580951454864819,HDAC4
514,GO_Biological_Process_2017b,"positive regulation of DNA-templated transcription, termination (GO:0060566)",1/472,0.3495410607090675,0.4214022130152696,0,0,2.4367428500062447,2.561343843869965,HDAC4
515,GO_Biological_Process_2017b,negative regulation of cellular hyperosmotic salinity response by negative regulation of transcription from RNA polymerase II promoter (GO:1900464),1/481,0.3549183614192739,0.4214022130152696,0,0,2.389950980392157,2.475672508431685,HDAC4
507,GO_Biological_Process_2017b,positive regulation of chromatin-mediated maintenance of transcription (GO:1904501),1/469,0.3477392393378797,0.4214022130152696,0,0,2.4527400703871294,2.5908352041132687,HDAC4
517,GO_Biological_Process_2017b,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter (GO:0072362),1/481,0.3549183614192739,0.4214022130152696,0,0,2.389950980392157,2.475672508431685,HDAC4
516,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter involved in meiotic cell cycle (GO:0010674),1/481,0.3549183614192739,0.4214022130152696,0,0,2.389950980392157,2.475672508431685,HDAC4
525,GO_Biological_Process_2017b,negative regulation of cellular response to alkaline pH by negative regulation of transcription from RNA polymerase II promoter (GO:1900463),1/481,0.3549183614192739,0.4214022130152696,0,0,2.389950980392157,2.475672508431685,HDAC4
524,GO_Biological_Process_2017b,"negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled (GO:2000805)",1/481,0.3549183614192739,0.4214022130152696,0,0,2.389950980392157,2.475672508431685,HDAC4
523,GO_Biological_Process_2017b,negative regulation of phosphatidylserine biosynthetic process by negative regulation of transcription from RNA polymerase II promoter (GO:1900526),1/481,0.3549183614192739,0.4214022130152696,0,0,2.389950980392157,2.475672508431685,HDAC4
522,GO_Biological_Process_2017b,negative regulation of transcription from RNA polymerase II promoter in response to copper ion (GO:0061398),1/481,0.3549183614192739,0.4214022130152696,0,0,2.389950980392157,2.475672508431685,HDAC4
527,GO_Biological_Process_2017b,negative regulation of phosphatidylcholine biosynthetic process by negative regulation of transcription from RNA polymerase II promoter (GO:1900473),1/481,0.3549183614192739,0.4214022130152696,0,0,2.389950980392157,2.475672508431685,HDAC4
520,GO_Biological_Process_2017b,negative regulation of filamentous growth of a population of unicellular organisms in response to starvation by negative regulation of transcription from RNA polymerase II promoter (GO:1902352),1/481,0.3549183614192739,0.4214022130152696,0,0,2.389950980392157,2.475672508431685,HDAC4
519,GO_Biological_Process_2017b,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter (GO:0072368),1/481,0.3549183614192739,0.4214022130152696,0,0,2.389950980392157,2.475672508431685,HDAC4
518,GO_Biological_Process_2017b,negative regulation of pseudohyphal growth by negative regulation of transcription from RNA polymerase II promoter (GO:1900462),1/481,0.3549183614192739,0.4214022130152696,0,0,2.389950980392157,2.475672508431685,HDAC4
521,GO_Biological_Process_2017b,negative regulation of ribosomal protein gene transcription from RNA polymerase II promoter (GO:0010688),1/481,0.3549183614192739,0.4214022130152696,0,0,2.389950980392157,2.475672508431685,HDAC4
561,GO_Biological_Process_2017b,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter (GO:1900477),1/496,0.3637873406483042,0.4223388651325959,0,0,2.3157456922162805,2.34164918599665,HDAC4
138,GO_Biological_Process_2018,negative regulation of transcription from RNA polymerase II promoter (GO:0000122),1/565,0.4031218621353314,0.4234229631061754,0,0,2.025239883187317,1.8399635978121285,HDAC4
562,GO_Biological_Process_2017b,negative regulation of chromatin silencing (GO:0031936),1/509,0.3713805138211477,0.4300195423192236,0,0,2.2549791570171376,2.2336202160276035,HDAC4
563,GO_Biological_Process_2017b,negative regulation of neuron apoptotic process by negative regulation of transcription from RNA polymerase II promoter (GO:1904089),1/534,0.3857428343305875,0.4454772889907048,0,0,2.146451826509215,2.044676447696062,HDAC4
139,GO_Biological_Process_2018,"regulation of transcription, DNA-templated (GO:0006355)",2/1598,0.4275318311869641,0.4458546239521197,0,0,1.4400062656641603,1.2236115337240323,HDAC4;NRG1
564,GO_Biological_Process_2017b,chromatin-mediated maintenance of transcription (GO:0048096),1/554,0.3970089647857222,0.4572878128421931,0,0,2.066695032443357,1.9092054664692495,HDAC4
599,GO_Biological_Process_2017b,positive regulation of phospholipid biosynthetic process by positive regulation of transcription from RNA polymerase II promoter (GO:1900413),1/721,0.4837532099670621,0.4951357425617795,0,0,1.5736928104575163,1.142784873110582,HDAC4
598,GO_Biological_Process_2017b,positive regulation of transcription involved in G2/M transition of mitotic cell cycle (GO:0090282),1/721,0.4837532099670621,0.4951357425617795,0,0,1.5736928104575163,1.142784873110582,HDAC4
597,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation (GO:2000721),1/721,0.4837532099670621,0.4951357425617795,0,0,1.5736928104575163,1.142784873110582,HDAC4
596,GO_Biological_Process_2017b,positive regulation of posterior gap gene transcription (GO:0007360),1/721,0.4837532099670621,0.4951357425617795,0,0,1.5736928104575163,1.142784873110582,HDAC4
600,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter during mitotic cell cycle (GO:0046022),1/721,0.4837532099670621,0.4951357425617795,0,0,1.5736928104575163,1.142784873110582,HDAC4
594,GO_Biological_Process_2017b,transcriptional activation by promoter-enhancer looping (GO:0071733),1/721,0.4837532099670621,0.4951357425617795,0,0,1.5736928104575163,1.142784873110582,HDAC4
592,GO_Biological_Process_2017b,positive regulation of starch catabolic process by positive regulation of transcription from RNA polymerase II promoter (GO:0035957),1/720,0.4832707874982981,0.4951357425617795,0,0,1.575963347786959,1.1460061050690529,HDAC4
591,GO_Biological_Process_2017b,positive regulation of filamentous growth of a population of unicellular organisms in response to starvation by positive regulation of transcription from RNA polymerase II promoter (GO:1904741),1/720,0.4832707874982981,0.4951357425617795,0,0,1.575963347786959,1.1460061050690529,HDAC4
590,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in meiotic cell cycle (GO:0010673),1/720,0.4832707874982981,0.4951357425617795,0,0,1.575963347786959,1.1460061050690529,HDAC4
589,GO_Biological_Process_2017b,positive regulation of cellular alcohol catabolic process by positive regulation of transcription from RNA polymerase II promoter (GO:1900422),1/720,0.4832707874982981,0.4951357425617795,0,0,1.575963347786959,1.1460061050690529,HDAC4
595,GO_Biological_Process_2017b,positive regulation of terminal gap gene transcription (GO:0007363),1/721,0.4837532099670621,0.4951357425617795,0,0,1.5736928104575163,1.142784873110582,HDAC4
593,GO_Biological_Process_2017b,positive regulation of transcription via serum response element binding (GO:0010735),1/721,0.4837532099670621,0.4951357425617795,0,0,1.5736928104575163,1.142784873110582,HDAC4
609,GO_Biological_Process_2017b,positive regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902895),1/725,0.4856786495626825,0.4951357425617795,0,0,1.564673383165421,1.130019773452194,HDAC4
602,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),1/722,0.4842352070875041,0.4951357425617795,0,0,1.5714285714285714,1.139575682538001,HDAC4
603,GO_Biological_Process_2017b,positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter (GO:0035948),1/723,0.4847167791599755,0.4951357425617795,0,0,1.5691706045299003,1.1363784746680536,HDAC4
604,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),1/724,0.4851979265596331,0.4951357425617795,0,0,1.566918883736067,1.133193190935309,HDAC4
605,GO_Biological_Process_2017b,SREBP signaling pathway (GO:0032933),1/725,0.4856786495626825,0.4951357425617795,0,0,1.564673383165421,1.130019773452194,HDAC4
606,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process (GO:2000763),1/725,0.4856786495626825,0.4951357425617795,0,0,1.564673383165421,1.130019773452194,HDAC4
607,GO_Biological_Process_2017b,positive regulation of central gap gene transcription (GO:0007357),1/725,0.4856786495626825,0.4951357425617795,0,0,1.564673383165421,1.130019773452194,HDAC4
608,GO_Biological_Process_2017b,positive regulation of SREBP signaling pathway (GO:2000640),1/725,0.4856786495626825,0.4951357425617795,0,0,1.564673383165421,1.130019773452194,HDAC4
588,GO_Biological_Process_2017b,positive regulation of ethanol catabolic process by positive regulation of transcription from RNA polymerase II promoter (GO:0061425),1/720,0.4832707874982981,0.4951357425617795,0,0,1.575963347786959,1.1460061050690529,HDAC4
610,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to nitrogen starvation (GO:0036278),1/725,0.4856786495626825,0.4951357425617795,0,0,1.564673383165421,1.130019773452194,HDAC4
611,GO_Biological_Process_2017b,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),1/726,0.486158948639852,0.4951357425617795,0,0,1.5624340770791074,1.12685816405929,HDAC4
612,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter in response to acidic pH (GO:0061402),1/727,0.4866388240637988,0.4951357425617795,0,0,1.5602009398800842,1.1237083055889487,HDAC4
613,GO_Biological_Process_2017b,regulation of potassium ion concentration by positive regulation of transcription from RNA polymerase II promoter (GO:0097301),1/728,0.4871182762124091,0.4951357425617795,0,0,1.557973946112145,1.1205701408849242,HDAC4
614,GO_Biological_Process_2017b,regulation of reactive oxygen species metabolic process by positive regulation of transcription from RNA polymerase II promoter (GO:1904488),1/729,0.4875973054306829,0.4951357425617795,0,0,1.5557530704589528,1.11744361324453,HDAC4
601,GO_Biological_Process_2017b,positive regulation of inositol biosynthetic process by positive regulation of transcription from RNA polymerase II promoter (GO:1900375),1/721,0.4837532099670621,0.4951357425617795,0,0,1.5736928104575163,1.142784873110582,HDAC4
587,GO_Biological_Process_2017b,transcriptional activation by promoter-terminator looping (GO:0090203),1/720,0.4832707874982981,0.4951357425617795,0,0,1.575963347786959,1.1460061050690529,HDAC4
572,GO_Biological_Process_2017b,positive regulation of invasive growth in response to glucose limitation by positive regulation of transcription from RNA polymerase II promoter (GO:0036095),1/720,0.4832707874982981,0.4951357425617795,0,0,1.575963347786959,1.1460061050690529,HDAC4
585,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in stress response to cadmium ion (GO:1902901),1/720,0.4832707874982981,0.4951357425617795,0,0,1.575963347786959,1.1460061050690529,HDAC4
615,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in defense response to fungus (GO:1901244),1/730,0.4880759120548141,0.4951357425617795,0,0,1.5535382877430808,1.1143286663381513,HDAC4
617,GO_Biological_Process_2017b,positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),1/733,0.4895092000326683,0.4951357425617795,0,0,1.5469302475088396,1.1050527508707135,HDAC4
565,GO_Biological_Process_2017b,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter (GO:0072369),1/720,0.4832707874982981,0.4951357425617795,0,0,1.575963347786959,1.1460061050690529,HDAC4
566,GO_Biological_Process_2017b,positive regulation of pyrimidine-containing compound salvage by positive regulation of transcription from RNA polymerase II promoter (GO:1904001),1/720,0.4832707874982981,0.4951357425617795,0,0,1.575963347786959,1.1460061050690529,HDAC4
567,GO_Biological_Process_2017b,positive regulation of ergosterol biosynthetic process by positive regulation of transcription from RNA polymerase II promoter (GO:0035961),1/720,0.4832707874982981,0.4951357425617795,0,0,1.575963347786959,1.1460061050690529,HDAC4
568,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter by histone modification (GO:1903757),1/720,0.4832707874982981,0.4951357425617795,0,0,1.575963347786959,1.1460061050690529,HDAC4
569,GO_Biological_Process_2017b,positive regulation of oligopeptide transport by positive regulation of transcription from RNA polymerase II promoter (GO:0035951),1/720,0.4832707874982981,0.4951357425617795,0,0,1.575963347786959,1.1460061050690529,HDAC4
586,GO_Biological_Process_2017b,positive regulation of peroxisome organization by positive regulation of transcription from RNA polymerase II promoter (GO:0061424),1/720,0.4832707874982981,0.4951357425617795,0,0,1.575963347786959,1.1460061050690529,HDAC4
571,GO_Biological_Process_2017b,positive regulation of flocculation via cell wall protein-carbohydrate interaction by positive regulation of transcription from RNA polymerase II promoter (GO:1900524),1/720,0.4832707874982981,0.4951357425617795,0,0,1.575963347786959,1.1460061050690529,HDAC4
573,GO_Biological_Process_2017b,positive regulation of sulfite transport by positive regulation of transcription from RNA polymerase II promoter (GO:0061426),1/720,0.4832707874982981,0.4951357425617795,0,0,1.575963347786959,1.1460061050690529,HDAC4
570,GO_Biological_Process_2017b,positive regulation of mating type switching by positive regulation of transcription from RNA polymerase II promoter (GO:1900423),1/720,0.4832707874982981,0.4951357425617795,0,0,1.575963347786959,1.1460061050690529,HDAC4
575,GO_Biological_Process_2017b,positive regulation of sulfate assimilation by positive regulation of transcription from RNA polymerase II promoter (GO:1900478),1/720,0.4832707874982981,0.4951357425617795,0,0,1.575963347786959,1.1460061050690529,HDAC4
584,GO_Biological_Process_2017b,positive regulation of pseudohyphal growth by positive regulation of transcription from RNA polymerase II promoter (GO:1900461),1/720,0.4832707874982981,0.4951357425617795,0,0,1.575963347786959,1.1460061050690529,HDAC4
583,GO_Biological_Process_2017b,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter (GO:0072363),1/720,0.4832707874982981,0.4951357425617795,0,0,1.575963347786959,1.1460061050690529,HDAC4
574,GO_Biological_Process_2017b,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter (GO:0072366),1/720,0.4832707874982981,0.4951357425617795,0,0,1.575963347786959,1.1460061050690529,HDAC4
582,GO_Biological_Process_2017b,positive regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901582),1/720,0.4832707874982981,0.4951357425617795,0,0,1.575963347786959,1.1460061050690529,HDAC4
581,GO_Biological_Process_2017b,positive regulation of purine nucleotide biosynthetic process by positive regulation of transcription from RNA polymerase II promoter (GO:1900418),1/720,0.4832707874982981,0.4951357425617795,0,0,1.575963347786959,1.1460061050690529,HDAC4
616,GO_Biological_Process_2017b,positive regulation of sodium ion transport by positive regulation of transcription from RNA polymerase II promoter (GO:0061423),1/731,0.4885540964858179,0.4951357425617795,0,0,1.5513295729250605,1.1112252439725694,HDAC4
579,GO_Biological_Process_2017b,positive regulation of ribosomal protein gene transcription from RNA polymerase II promoter (GO:0060963),1/720,0.4832707874982981,0.4951357425617795,0,0,1.575963347786959,1.1460061050690529,HDAC4
578,GO_Biological_Process_2017b,positive regulation of snRNA transcription from RNA polymerase II promoter (GO:1905382),1/720,0.4832707874982981,0.4951357425617795,0,0,1.575963347786959,1.1460061050690529,HDAC4
577,GO_Biological_Process_2017b,positive regulation of termination of RNA polymerase II transcription (GO:1904595),1/720,0.4832707874982981,0.4951357425617795,0,0,1.575963347786959,1.1460061050690529,HDAC4
576,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter by calcium-mediated signaling (GO:1900622),1/720,0.4832707874982981,0.4951357425617795,0,0,1.575963347786959,1.1460061050690529,HDAC4
580,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901228),1/720,0.4832707874982981,0.4951357425617795,0,0,1.575963347786959,1.1460061050690529,HDAC4
618,GO_Biological_Process_2017b,positive regulation of DNA repair by positive regulation of transcription from RNA polymerase II promoter (GO:1900404),1/739,0.4923644136300784,0.4968815183422809,0,0,1.5338753387533874,1.0868061402096492,HDAC4
619,GO_Biological_Process_2017b,positive regulation of transcription of Notch receptor target (GO:0007221),1/744,0.4947322303753704,0.4981285614763455,0,0,1.5231573113767714,1.0719046114281638,HDAC4
620,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter involved in defense response to Gram-negative bacterium (GO:1902097),1/756,0.5003725037638211,0.5026573097170806,0,0,1.4980132450331125,1.0372280416115367,HDAC4
140,GO_Biological_Process_2018,positive regulation of gene expression (GO:0010628),1/771,0.5073392412269715,0.5253299944619705,0,0,1.46768525592055,0.9959350865712352,HDAC4
141,GO_Biological_Process_2018,positive regulation of transcription from RNA polymerase II promoter (GO:0045944),1/848,0.5416809069633209,0.5569395240608792,0,0,1.3289117299812487,0.8147267893870057,HDAC4
621,GO_Biological_Process_2017b,"positive regulation of transcription, DNA-templated (GO:0045893)",1/1004,0.6044475151422631,0.6058243887530657,0,0,1.1130725470646885,0.5603657287085152,HDAC4
142,GO_Biological_Process_2018,cellular protein modification process (GO:0006464),1/1001,0.6033210645171119,0.6159781497867016,0,0,1.1165882352941177,0.5642184876685615,PTPRD
143,GO_Biological_Process_2018,regulation of gene expression (GO:0010468),1/1037,0.6166407185063515,0.6252051729300507,0,0,1.0757438110379287,0.5200884925798641,HDAC4
144,GO_Biological_Process_2018,"positive regulation of transcription, DNA-templated (GO:0045893)",1/1120,0.6457582943028364,0.650211799780787,0,0,0.9915891289491668,0.4336516763809753,HDAC4
622,GO_Biological_Process_2017b,positive regulation of transcription from RNA polymerase II promoter (GO:0045944),1/1175,0.6638884845651349,0.6638884845651349,0,0,0.942378995891372,0.3860371576961133,HDAC4
145,GO_Biological_Process_2018,regulation of transcription from RNA polymerase II promoter (GO:0006357),1/1478,0.7490551439879347,0.7490551439879347,0,0,0.7369867378230913,0.2129469192399496,HDAC4
